dls_datetime,drug_link,x1,x2
2020-09-18T01:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-substance-p-antagonist-receptor-quantifier,Abbreviation:,[18F]SPA-RQ
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18]F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAc
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,18F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Chemical structure:,1-(2′-deoxy-2′-[18F]fluoroarabinofuranosyl) cytosine
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Synonym:,L-fluorine F 18-FMAC
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Chemical structure:,2’-deoxy-2’-18F-fluoro-5-methyl-beta-L-arabinofuranosylcytosine
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Synonym:,Fluorine F 18 ML-10
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Foreign brand name:,[18F]-ApoSense
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Chemical structure:,[18F]-2-(5-fluoro-pentyl)-2-methyl-malonic-acid
2020-09-18T01:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/61cu-atsm,NA,NA
2020-09-18T01:07:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18hx4,NA,NA
2020-09-18T01:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f18vm4-037,NA,NA
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST 17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST-17
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11-beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11bHSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11b-HSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11β-HSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD 4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD-4017
2020-09-18T01:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11c-topotecan,NA,NA
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Synonym:,iodine I 123 IMP-1095
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Chemical structure:,2-(3-{l-carboxy-5-[3-(4-iodo-phenyl)-ureido]-pentyl}-ureido)-pentanedioic acid
2020-09-18T01:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/14c-bms-275183,NA,NA
2020-09-18T01:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/16-16-dimethyl-prostaglandin-e2,Abbreviation:,dmPGE2
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Synonym:,reporter probe 18F-FHBG
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Chemical structure:,9-(4-18F-fluoro-3-[hydroxymethyl]butyl)guanine
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Synonym:,fluorine F 18 fluoroacetate
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,(18)F-FAC
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,F-AC
2020-09-18T01:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoromisonidazole,Abbreviation:,18F-FMISO
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,(18)F-FB-mini-PEG-E[c(RGDyK)](2)
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,[18F] FPRGD2
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,18F-FPRGD2
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,O-desulfated heparin
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,PGX-ODSH
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Abbreviation:,ODSH
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX 01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX-01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX100
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX-100
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Synonym:,FAU
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Chemical structure:,1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2-FF containing SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2FF-containing SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Code name:,SGN-2FF
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Synonym:,fluorine 18 ((18)F) FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,[18F] FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PEG3-RGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,PEG3-E[c(RGDyk)]2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Code name:,104150
2020-09-18T01:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2g-1-tcr-retroviral-vector-transduced-lymphocytes,NA,NA
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Synonym:,2-hydroxyflutamide controlled-release formulation
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Foreign brand name:,Liproca
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Foreign brand name:,Minerval
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2OHOA
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2-OHOA
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-ME
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-Methoxy Estradiol
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,US brand name:,Panzem
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Abbreviation:,2ME2
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Chemical structure:,"(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol"
2020-09-18T01:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/34-methylenedioxymethamphetamine,Abbreviation:,MDMA
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,Synonym:,nicotine conjugate vaccine
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,US brand name:,NicVax
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Abbreviation:,ECyd
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Code name:,TAS-106
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Chemical structure:,1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Synonym:,deazauridine
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Abbreviation:,DAU
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Chemical structure:,"2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl4-hydroxy-1-(beta-D-ribopentofuranosyl)-2-pyridone"
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLacental eXpanded-R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLX-R18 cells
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX RAD
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX-R18
2020-09-18T01:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797360,US brand name:,3M Cavilon Advanced Skin Protectant
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,(2S)-2-amino-4-[F-18]-fluoro pentanedioic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,[F-18]BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,4-[(18)F]fluoro L-glutamic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,fluorine F 18-BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 858050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 85-8050
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous 4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous MUC16ecto-targeting EGFR-secreting T lymphocytes
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Synonym:,iododoxorubicin
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Abbreviation:,IDOX
2020-09-18T01:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-nitroestrone-3-methyl-ether,Synonym:,4-Nitroestrone
2020-09-18T01:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-peptide-melanoma-vaccine,NA,NA
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2 T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2-modified T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4S-GD2-CAR-T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,GD2-specific 4th generation chimeric antigen receptor-modified T Cells
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Synonym:,4'-thio-2'-deoxycytidine
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,TdCyd
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,T-dCyd
2020-09-18T01:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-18ffluorouracil,NA,NA
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Entonox
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Kalinox 170 bar
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,5-Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdC
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Chemical structure:,5-aza-4-thio-2-deoxycytidine
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCC colon heptapeptide
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCCFPAQ-GGGSK-(5-FITC)-NH2
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,5-FITC-labeled 7-AA peptide
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,GI heptapeptide
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Chemical structure:,Ala1-Ser2-Tyr3-Asn4-Tyr5-Asp6-Ala7-Gly8- Gly9-Gly10-Ser11-Lys12 (5-FITC) -NH213
2020-09-18T01:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluoro-2-deoxycytidine,Abbreviation:,FdCyd
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Synonym:,low-dose 5-fluorouracil/salicylic acid
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Foreign brand name:,Actikerall
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Abbreviation:,low-dose 5-FU/SA
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Code name:,LAS 41005
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin 4 receptor agonist TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin agonist TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK 954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TD-8954
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Synonym:,6MHP vaccine
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Abbreviation:,6MHP
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Synonym:,alpha-lipoic acid analogue CPI-613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI 613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI-613
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,6-azauracil riboside
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,azauridine
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,riboazauracil
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Abbreviation:,6-AZUR
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Chemical structure:,"1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl2-beta-D-ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine riboside6-azauracil-.beta.-D-riboside"
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Synonym:,PFKFB3 Inhibitor PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,ACT-PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,PFK-158
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Synonym:,17βHSD5 inhibitor ASP9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP 9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Chemical structure:,(4-(2-hydroxy-2-methylpropyl)piperidin-1-yl)(5-methoxy-1H-indol-2-yl)methanone
2020-09-18T01:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-cyanoquinocarcinol,Code name:,DX-52-1
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Code name:,UCN-01
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Vesanoid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Airol
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Chemical structure:,"8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo[a, g]cyclonona[cde] trinden-1-one, 2,3,9,10,11, 12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)"
2020-09-18T01:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/851b-gel,NA,NA
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,TLR7 agonist 852A
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,Toll-like receptor agonist 852A
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,US brand name:,Bag Balm
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,Foreign brand name:,Bag Balm
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Synonym:,A-101 solution
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Code name:,A-101
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS 100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS-100850
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,US brand name:,Ziagen
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,Code name:,1592U89
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Synonym:,monoclonal antibody ACA125 anti-idiotype vaccine
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Foreign brand name:,VaccinOvar
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Synonym:,Plenaxis
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,PPI-149
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,R-3827
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTL A4-Ig B7 Inhibitor
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTLA4-Ig
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,cytotoxic T lymphocyte-associated antigen-4
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,US brand name:,Orencia
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,BMS-188667
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,RG2077
2020-09-18T01:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abbv-221,NA,NA
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Synonym:,amphotericin B-lipid complex
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,Abelcet
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,AmBisome
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Acronym:,L-AMB
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Synonym:,CDK4/6 dual inhibitor LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,US brand name:,Verzenio
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Code name:,LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Chemical structure:,"2-pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)"
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,beta-retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,tretinoinum
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,Vitamin A Acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aknoten
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Avita
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Renova
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A MICRO
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Cordes Vas
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Dermairol
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Epi-Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Eudyna
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Retisol-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A Forte
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Vitinoin
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Abbreviation:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Code name:,Ro 5488
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Chemical structure:,"(All-E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid"
2020-09-18T01:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat,Code name:,PCI-24781
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,US brand name:,Zytiga
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,Code name:,CB7630
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Ablavar
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Vasovist
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS 325
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS-325
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Albumin-Stabilized Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab-paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nanoparticle albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,protein-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,US brand name:,Abraxane
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Code name:,ABI-007
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,Synonym:,oxiplex/AP gel
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,US brand name:,Intercoat
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Synonym:,human fibrinogen/thrombin patch
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,US brand name:,TachoSil
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Abbreviation:,HFTP
2020-09-18T01:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge,US brand name:,Gelfoam
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,AMP hemostatic powder
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,Endo-Clot
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,US brand name:,EndoClot
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Abbreviation:,AMP
2020-09-18T01:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-510,NA,NA
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Code name:,E7010
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Chemical structure:,N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,ABVD
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,Adriamycin-bleomycin-vinblastine-dacarbazine regimen
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,bleomycin/dacarbazine/doxorubicin/vinblastine
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Abbreviation:,BLEO/DOX/DTIC/VBL
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,ABVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide regimen
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE regimen
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,ABVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide-prednisone-cyclophosphamide regimen
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC regimen
2020-09-18T01:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-regimen,Synonym:,Adriamycin-cyclophosphamide regimen
2020-09-18T01:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acadesine,Chemical structure:,5-aminoimidazole-4-carboxamide riboside
2020-09-18T01:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acai-berry-juice,Synonym:,acai juice
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,Bruton tyrosine kinase inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,BTK inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,US brand name:,Calquence
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Code name:,ACP-196
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Synonym:,p110beta/delta PI3K Inhibitor GS-9820
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,CAL-120
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,GS-9820
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,US brand name:,Precose
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Code name:,Bay g 5421
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Chemical structure:,"O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose"
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,US brand name:,Accolate
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,Chemical structure:,"carbamic Acid,(3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl estercyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate"
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-vitamin A acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,isotretinoinum
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,neovitamin A
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,Neovitamin A Acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Accutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Amnesteem
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Cistane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Claravis
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Sotret
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Accure
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrex
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrexin
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Oratane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roacutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Abbreviation:,13-CRA
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Code name:,Ro 4-3780
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)2cis-4-trans-6-trans-8-trans-nonatetraenoic Acid"
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Synonym:,gemcitabine ProTide
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,US brand name:,Acelarin
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC 1031
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC-1031
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,AlloDerm
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,DermaMatrix
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,Acronym:,ACDM
2020-09-18T01:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acenocoumarol,NA,NA
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Synonym:,perindopril tert-butylamine
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,US brand name:,Aceon
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Foreign brand name:,Coversyl
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,MCN-A-2833-109
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,S-9490-3
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Chemical structure:,"1H-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-methyl-2-propanamine(1:1)"
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Synonym:,paracetamol
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,US brand name:,Tylenol
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Abbreviation:,ACMP
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Chemical structure:,N-(4-hydroxyphenyl)acetamide
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,"acetic acid, glacial"
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,glacial acetic acid
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Synonym:,Cyclamide
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,US brand name:,Dymelor
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Foreign brand name:,Dimelin
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Chemical structure:,1-(p-acetylbenzenesulfonyl)-3-cyclohexylurea3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamideN-(p-acetylbenzenesulfonyl)-N'-cyclohexylureaN-(p-acetylphenylsulfonyl)-N'-cyclohexylurea
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,L-Alpha-acetamido-beta-mercaptopropionic Acid
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-Acetyl Cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-3-mercaptoalanine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetylcysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-L-cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,US brand name:,Mucomyst
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Airbron
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Broncholysin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Brunac
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fabrol
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluatox
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucetin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluprowit
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Muco Sanigen
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucocedyl
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolator
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolyticum
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucosolvin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucret
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Neo-Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Parvolex
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Respaire
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Tixair
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Abbreviation:,NAC
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Synonym:,aspirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Aspergum
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Ecotrin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Empirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Entericin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Extren
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Measurin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Abbreviation:,ASA
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Chemical structure:,2-(acetyloxy)benzoic Acid
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide capsule
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide tablet
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,Polycap
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Foreign brand name:,Quintapill
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,US brand name:,Achromycin
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,Chemical structure:,"(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,US brand name:,Aciphex
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Pariet
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Rablet
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Synonym:,Trimethylmethoxyphenyl-retinoic acid
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Etretin
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Soriatane
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Foreign brand name:,Neotigason
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro 10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro-10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Chemical structure:,"(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid"
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,AT-125
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,U-42126
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrolum
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,Sinestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,stilboestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Acnestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Cyren A
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Deladumone
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Diastyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Domestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrobene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrosyn
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Fonatol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Makarol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Milestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Neo-Oestronol I
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Palestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbetin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestroform
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synthoestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Vagestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Antigestil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Apstil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Boestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Bufon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Distilbene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Grafestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Microest
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Oestromensyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Serral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sexocretin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sibol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilboefral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilkap
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Abbreviation:,DES
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Chemical structure:,"(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol3,4-bis(p-hydroxyphenyl)-3-hexene4,4'-dihydroxy-alpha,beta-diethylstilbenealpha,alpha'-diethylstilbenedioltrans-bis-(hydroxy-4-phenyl)-3,4 hexene-3"
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,Nimustine Hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,pimustine hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,US brand name:,ACNU 50
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Foreign brand name:,Nidran
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Abbreviation:,ACNU
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Chemical structure:,N'-[4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Synonym:,acodazole hydrochloride
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Chemical structure:,"acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-, monohydrochloride (9CI)"
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,acoustic fluid
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,brain mimicking fluid
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Abbreviation:,BMF
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Abbreviation:,DACA
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Code name:,XR5000
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-T
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-Taxol regimen
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,Adriamycin cyclophosphamide-Taxol regimen
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Synonym:,"immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa chain dimer"
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,US brand name:,Actemra
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Foreign brand name:,RoActemra
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Abbreviation:,MRA
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Code name:,R-1569
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b conjugate vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b oligosaccharide conjugate vacccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Hib TITER vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,ActHIB
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,HibTITER
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,PedvaxHIB
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Synonym:,ursodeoxycholic acid
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,Actigall
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,URSO
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Foreign brand name:,Deursil
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Abbreviation:,UDCA
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Chemical structure:,"(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-oic acid"
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,N(sup 2)-L-methionyl-1-139-interferon G
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,recombinant interferon gamma-1b
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,US brand name:,Actimmune
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Synonym:,nordihydroguaiaretic acid
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,US brand name:,Actinex
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Abbreviation:,NDGA
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Chemical structure:,"4,4'-(2,3-Dimethyl-1,4-butanediyl)bis[1,2-benzenediol]"
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,US brand name:,Tymlos
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BA058
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BIM-44058
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,humanized monoclonal antibody MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,monoclonal antibody anti-alpha V beta 3 integrin MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,US brand name:,Abegrin
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Code name:,MEDI-522
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclarubicin Hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Antibiotic MA144-A1
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinomycine
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinon
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclaplastin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Jaclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Code name:,MA144-A1
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Synonym:,actinium-225-labeled humanized anti-CD33 monoclonal antibody HuM195
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Abbreviation:,225Ac-HuM195
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,[Ac-225]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,225Ac-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-FPI-1397-FPI-1175
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-labeled FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,[225Ac]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX 01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX-01
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 MOAB J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 monoclonal antibody J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Abbreviation:,225Ac-J591
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Actiq
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Oralet
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Sublimaze
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,recombinant tissue plasminogen activator
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,t-PA
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,US brand name:,Activase
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Abbreviation:,rt-PA
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,aMIL
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM010
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,MIL
2020-09-18T01:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-norethindrone-acetate-tablet,US brand name:,Activella
2020-09-18T01:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ih636-grape-seed-proanthocyanidin-extract,US brand name:,ActiVin
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Synonym:,activin A inhibitor STM 434
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Code name:,STM 434
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Synonym:,activin type 2A receptor Fc fusion protein KER-050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER 050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER-050
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Synonym:,IMA101 T cells
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,US brand name:,ACTolog IMA101
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Code name:,IMA101
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Synonym:,Risedronate
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,US brand name:,Actonel
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Abbreviation:,RISE
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Code name:,NE-58095
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Chemical structure:,monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate hemipentahydrate
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,Synonym:,metformide HCl/pioglitazone HCl ER tablet
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,US brand name:,ACTOplus Met XR
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,Synonym:,pioglitazone HCl
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,US brand name:,Actos
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI-1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,HTI 1968
2020-09-18T01:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/531923,US brand name:,Zovirax
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,US brand name:,Zovirax for injection
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,Chemical structure:,"2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one monosodium salt9-[(2-hydroxyethoxy)methyl]guanine monosodium salt"
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,croysulfone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,diphenasone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,dumitone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,novophone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulfona-mae
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulphadione
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Aczone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Avlosulfon
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Disulone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Eporal
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Undolac
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DADPS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DDS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Code name:,1358F
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Chemical structure:,"4,4'-sulfonylbisbenzamine4,4'-sulfonylbisbenzeneamine4,4'-sulfonyldianilinebis(4-aminophenyl)sulfone"
2020-09-18T01:22:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel-5pct,US brand name:,Aczone Gel
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,"Ad5 [E1-, E2b-]-HER2/neu vaccine"
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,adenovirus type 5 E1/E2b-deleted HER2/neu vaccine ETBX-021
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Code name:,ETBX-021
2020-09-18T01:22:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5sstr-tkrgd,NA,NA
2020-09-18T01:22:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-cmv-nis,Synonym:,recombinant type 5 adenovirus carrying the human NIS gene linked to the CMV promotor
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adeno-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adenovirus p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,US brand name:,ADVEXIN
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad5CMV-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,INGN-201
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,RPR/INGN-201
2020-09-18T01:23:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5f35-lmp1-lmp2-transduced-autologous-dendritic-cells,NA,NA
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Synonym:,Ad5-SGE-REIC/Dkk-3
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG 201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG-201
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,Ad5-survivin-transduced autologous DC vaccine
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,autologous dendritic cell adenovirus type 5-survivin vaccine
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Code name:,autologous DC:AdmS
2020-09-18T01:23:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-adp,NA,NA
2020-09-18T01:23:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-hil12,Synonym:,oncolytic adenovirus Ad5-yCD/mutTKSR39rep-hIL12
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Synonym:,diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Adacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Daptacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Infanrix
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Tripedia
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Abbreviation:,DTaP
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Synonym:,Globo H-KLH immunostimulant OPT-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OBI-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OPT-822
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,US brand name:,Humira
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,D2E7
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,LU200134
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Chemical structure:,"immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer"
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Adanon
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Althose
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Dolophine
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Methadose
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Adapin
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Sinequan
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Chemical structure:,"2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one"
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 ADC SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,US brand name:,Adcetris
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Abbreviation:,cAC10-vcMMAE
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Code name:,SGN-35
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Synonym:,"D,L-amphetamine"
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall XR
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Abbreviation:,SLI381
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Synonym:,"D,L-amphetamine"
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall XR
2020-09-18T01:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Abbreviation:,SLI381
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,ADE
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,AraC-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine/daunorubicin/etoposide
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Abbreviation:,ARA-C/DNR/VP-16
2020-09-18T01:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adecatumumab,Code name:,MT201
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,US brand name:,Hepsera
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,Code name:,GS-0840
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Synonym:,A2AR antagonist NIR178
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Code name:,NIR 178
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Synonym:,A2AR antagonist PBF-509
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Code name:,PBF-509
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Synonym:,A2A/PDE-10 inhibitor PBF-999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF 999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF-999
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,A2AR/A2BR antagonist AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,dual A2AR/A2BR antagonist AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB 928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB-928
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Synonym:,A2BR Antagonist PBF-1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF 1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF1129
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Synonym:,A3AR agonist CF102
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Abbreviation:,Cl-IB-MECA
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Code name:,CF102
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Chemical structure:,2-chloro-N6-(3-iodobenzyl)-9-[5-(methylcarbamoyl)--D-ribofuranosyl]adenine
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Synonym:,adenosine-A2A receptor-targeting agent CPI-444
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Code name:,CPI-444
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Synonym:,adenovector encoding IL24
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Code name:,INGN 241
2020-09-18T01:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748904,Code name:,BPX-201
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX 051
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX-051
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF 06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF-06936308
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX 061
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX-061
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Synonym:,Adenoviral PSA Prostate Cancer Vaccine ETBX-071
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Code name:,ETBX-071
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,GAd-209-FSP
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,great ape adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Synonym:,adenoviral TSNA priming vaccine GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,US brand name:,priming cancer vaccine GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRTC901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT-C901
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Synonym:,"adenoviral vector Ad5 [E1-, E2b-]-CEA vaccine"
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Abbreviation:,"Ad5[E1-,E2b-]-CEA vaccine"
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Code name:,ETBX-011
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,AdAptVEGF-C adenoviral vector LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,VEGFC-expressing gene therapeutic LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Foreign brand name:,Lymfactin
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX 1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX-1101
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Synonym:,DC-RTS-IL-12
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Code name:,INXN-3001/1001
2020-09-18T01:38:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-5-human-guanylyl-cyclase-c-padre-vaccine,Synonym:,Ad5-hGCC-PADRE vaccine
2020-09-18T01:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-b7-1,NA,NA
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Synonym:,adenovirus encoding purine nucleoside phosphorylase
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,US brand name:,Gedeptin
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Code name:,Ad/PNP
2020-09-18T01:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-human-aquaporin-1,Abbreviation:,AdhAQP1
2020-09-18T01:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-rat-her-2-neu,NA,NA
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Abbreviation:,Ad-rhENDO
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Code name:,E10A
2020-09-18T01:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735883,Synonym:,AdVTMM2-transduced dendritic cell vaccine
2020-09-18T01:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-her2-transduced-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Synonym:,Adenoviral Vector
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Abbreviation:,ADV
2020-09-18T01:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/727131,NA,NA
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-expressing mutant HPV E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-HPV E6E7 vaccine
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-HPV E6E7 vaccine
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenovirus vaccine expressing mutant HPV E6 and E7
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,US brand name:,Mobilan
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,Code name:,M-VM3
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Synonym:,adenovirus-interleukin-12
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Abbreviation:,Ad.hIL-12
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Synonym:,adenovirus-mediated human interleukin-12 INXN-2001 plus activator ligand INXN-1001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Abbreviation:,Ad-RTS-IL-12 plus AL
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,INXN-2001/1001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,ZIN ATI-001
2020-09-18T01:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-p53-transduced-dendritic-cell-vaccine,Abbreviation:,Ad.p53-DC vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,Ad/PSA vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,adenovirus/PSA vaccine
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,DCs expressing CMCA9 gene
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,dendritic cells transduced with AdGMCA9 expressing GM-CSF-carbonic anhydrase IX fusion protein
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Abbreviation:,DC-AdGMCAIX
2020-09-18T01:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adh-1,US brand name:,Exherin
2020-09-18T01:40:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-flt3l,NA,NA
2020-09-18T01:40:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-tk,NA,NA
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose derived stem cells SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose-derived expanded MSCs SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,ADSCs SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM 010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM-010
2020-09-18T01:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-regenerative-cells,Acronym:,ADRC
2020-09-18T01:40:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-stromal-vascular-fraction-cells,Synonym:,adipose-derived SVF cells
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD154 ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD40L ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,recombinant adenovirus encoding CD40 ligand ISF35-transduced B lymphocytes
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab emtansine
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 antibody-drug conjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 immunoconjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,US brand name:,Kadcyla
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Abbreviation:,T-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,PRO132365
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,RO5304020
2020-09-18T01:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adozelesin,Code name:,"U-73,975"
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,adenovirus-mediated REIC/Dkk-3 secretory protein
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,Ad-REIC/dickkopf homolog 3
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,ACTH
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,acthar
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,adrenocorticotropin
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,corticotropin
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Abbreviation:,CCTROP
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Synonym:,adaoviral-rheoswitch therapeutic system-human interleukin 12
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN 2001
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN-2001
2020-09-18T01:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrtvp-1-transduced-prostate-cancer-cell-based-vaccine,Synonym:,Adenoviral vector-mediated RTVP-1 gene-modified prostate cancer cell-based vaccine
2020-09-18T01:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-sig-hmuc-1-ecdcd40l-vaccine,Synonym:,Ad-sig-hMUC1/ecdCD40L adenoviral vector vaccine
2020-09-18T01:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ae37-peptide-gm-csf-vaccine,NA,NA
2020-09-18T01:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aee788,NA,NA
2020-09-18T01:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aeg35156,US brand name:,GEM640
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Barseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Cortifan
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,cortisol
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Domolene
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Komed-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Aeroseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Barseb HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cetacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cort-Dome
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortef
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortenema
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortispray
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortril
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Dermacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Domolene-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Eldecort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hydrocortone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hytone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Komed HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Nutracort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Proctocort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Rectoid
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Abbreviation:,HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Chemical structure:,"(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione"
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized GCB
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized gemcitabine
2020-09-18T01:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-sargramostim,Synonym:,aerosol GM-CSF
2020-09-18T01:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-aldesleukin,Synonym:,aerosolized recombinant IL-2
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Synonym:,aerosolized liposomal 9-nitrocamptothecin
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Code name:,L9NC
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Aerrane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Forane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Isoflo
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,Chemical structure:,"1-chloro-2,2,2-trifluoroethyl difluoromethyl ether (SN); 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane"
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Synonym:,OL(1)p53
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,US brand name:,Aezea®
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Code name:,EL625
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Code name:,CUV1647
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Chemical structure:,N-acetyl-L-serinyl-L-tyrosyl-L-seryl-(2S)-2-aminohexanoyl-L-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophanylglycyl-L-lysyl-L-prolyl-L-valinamide
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,US brand name:,Gilotrif
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,Code name:,BIBW 2992 MA2
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitac
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitak
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,CGP 64128A
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,LY900003
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitac
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitak
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,CGP 64128A
2020-09-18T01:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,LY900003
2020-09-18T01:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afimoxifene,Synonym:,4-Hydroxy-Tamoxifen
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Synonym:,42-O-(2-hydroxy)ethyl rapamycin
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor Disperz
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Zortress
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Certican
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Votubia
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Code name:,RAD001
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Synonym:,42-O-(2-hydroxy)ethyl rapamycin
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor Disperz
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Zortress
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Certican
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Votubia
2020-09-18T01:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Code name:,RAD001
2020-09-18T01:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-tablets-for-oral-suspension,US brand name:,Afinitor Disperz
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Synonym:,Sulindac Sulfoxide
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Aflodac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Clinoril
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Algocetil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Apo-Sulin
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Arthrocine
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Artribid
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Citireuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Clisundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Imbaral
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Novo-Sundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumofil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumyl
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sudac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulinol
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulreuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Abbreviation:,SULIN
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Code name:,MK-231
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Chemical structure:,(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acidcis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2020-09-18T01:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp-gene-hepatocellular-carcinoma-vaccine,NA,NA
2020-09-18T01:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp464,NA,NA
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,Akt inhibitor GSK2110183
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,GSK2110183
2020-09-18T01:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ag-024322,NA,NA
2020-09-18T01:43:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agaricus-blazei-murill-extract,NA,NA
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,CpG 7909
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,PF-3512676
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,AC 013773
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP-32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX 105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX-105
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding herpes simplex virus thymidine kinase
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding HSV thymidine kinase
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,Ad HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,adeno-HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,ADV-tk
2020-09-18T01:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-cd40-monoclonal-antibody-adc-1013,Code name:,ADC-1013
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 agonist antibody INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 monoclonal antibody INCAGN0194
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,monoclonal antibody INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Code name:,INCAGN01949
2020-09-18T01:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6383,Code name:,MEDI6383
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Synonym:,agonistic anti-CD134 monoclonal antibody MEDI6469
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Code name:,MEDI6469
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,Influenza Vaccine
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,"influenza virus vaccine, trivalent, types A and B"
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,TIV
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Agriflu
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluarix
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flublok
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,FluLaval
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flushield
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluvirin
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluzone
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,US brand name:,Agrylin
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,Foreign brand name:,Thromboreductin
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,cortisol sodium succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hycorace
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RG7853
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone 21-Sodium Succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone Na succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Sodium hydrocortisone succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Cortef
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,A-Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Emergent-EZ
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Solu-Cortef
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Buccalsone
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Corlan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Cortop
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Efcortelan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Flebocortid
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hidroc Clora
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydro-Adreson
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Kinogen
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nositrol
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Sinsurrene
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Abbreviation:,HDC
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Chemical structure:,"(11beta)-21-(3-carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, monosodium salt"
2020-09-18T01:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aim2-1-ht001-1-taf1b-1-frameshift-peptide-vaccine,Abbreviation:,AIM2(-1)/HT001(-1)/TAF1B(-1) FSP vaccine
2020-09-18T01:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ak-3012,NA,NA
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,AKR1C3-activated prodrug TH-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,aldo-keto reductase 1c3-activated prodrug OBI-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH-3424
2020-09-18T01:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-bay1125976,Code name:,BAY1125976
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,US brand name:,Archexin
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,Code name:,RX-0201
2020-09-18T01:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-arq-092,Code name:,ARQ 092
2020-09-18T01:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-gsk2141795,Code name:,GSK2141795
2020-09-18T01:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-ly2780301,Code name:,LY2780301
2020-09-18T01:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-mk2206,Code name:,MK2206
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Code name:,SRI13668
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Chemical structure:,"2,10-dicarbethoxy-6-methoxy-5,7-dihydro-indolo[2,3-b]carbazole"
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,ONC201
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,TIC10
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,Synonym:,lidocaine HCl ophthalmic gel
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,US brand name:,Akten
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-1/2-treated Tumor Infiltrating Lymphocytes
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-treated TIL
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,AKTi-treated TILs
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,Synonym:,netupitant/palonosetron hydrochloride
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,US brand name:,Akynzeo
2020-09-18T01:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796,US brand name:,Alantel
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Bilutac
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Proftril
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Albenza
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Zentel
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Code name:,SKF 62979
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Bilutac
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Proftril
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Albenza
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Zentel
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Code name:,SKF 62979
2020-09-18T01:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,albumin-conjugating platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin/maleimide-based complex BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP 114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP-114
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,Synonym:,salbutamol sulfate
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Proventil
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Ventolin
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,absolute ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethyl alcohol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,methylcarbinol
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,US brand name:,Aldactone
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Foreign brand name:,Spiroctan
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Abbreviation:,SPL
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Code name:,SC 9420
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Chemical structure:,"17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate"
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,US brand name:,Aldara
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Abbreviation:,IMQ
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,R 837
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,S 26308
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Chemical structure:,"1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline"
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human IL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human interleukin-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,US brand name:,Proleukin
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Abbreviation:,r-serHuIL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Chemical structure:,125-L-serine-2-133-interleukin 2
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Synonym:,doxorubicin prodrug INNO-206
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Code name:,INNO-206
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,ALK inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,anaplastic lymphoma kinase inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,US brand name:,Alecensa
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Foreign brand name:,Alecensa
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF-802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RO5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,UNII-LIJ4CT1Z3Y
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Chemical structure:,"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-"
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,ALK inhibitor CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,anaplastic lymphoma kinase inhibitor CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,US brand name:,Alecensa
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Foreign brand name:,Alecensa
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF-802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,CH5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RG7853
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RO5424802
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,UNII-LIJ4CT1Z3Y
2020-09-18T01:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Chemical structure:,"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-"
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,US brand name:,Amevive
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,Code name:,LFA3TIP
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,anti-CD52 monoclonal antibody
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody CD52
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,US brand name:,Campath
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Foreign brand name:,MabCampath
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Abbreviation:,MoAb CD52
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronic Acid Monosodium Salt Trihydrate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Binosto
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Fosamax
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Adronat
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Alendros
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Onclast
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,G-704650
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,MK-217
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Alesse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Aviane
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Enpresse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Lessina
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levlite
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levora
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Microgynon
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Nordette
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Portia
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonale
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonique
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Trivora
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,US brand name:,Alfenta
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,Foreign brand name:,Rapifen
2020-09-18T01:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,US brand name:,Alfenta
2020-09-18T01:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,Foreign brand name:,Rapifen
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,alpha interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,leukocyte interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblast interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblastoid interferon
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,gammaphos
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,US brand name:,Alferon
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Synonym:,ASK120067
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST 2818
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST2818
2020-09-18T01:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfuzosin-hydrochloride,US brand name:,Uroxatrol
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,"Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Pancreatic Tumor Cell Vaccine"
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,Alpha-Gal Pancreatic Cancer Vaccine
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,US brand name:,Hyperacute-Pancreatic Cancer Vaccine
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Synonym:,multitargeted antifolate
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,US brand name:,Alimta
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Abbreviation:,MTA
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Code name:,LY231514
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Chemical structure:,"L-glutamic acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt"
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,US brand name:,Alinia
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,Chemical structure:,"benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-salicylamide, N-(5-nitro-2-thiazolyl)-, acetate(ester)"
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,BAY-80-6946 dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,copanlisib dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,US brand name:,Aliqopa
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Chemical structure:,"5-pyrimidinecarboxamide, 2-amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, hydrochloride (1:2)"
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Synonym:,Aurora A kinase inhibitor MLN8237
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Code name:,MLN8237
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Chemical structure:,"benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-"
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Synonym:,9-cis-retinoic acid
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,US brand name:,Panretin
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panretyn
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panrexin
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Abbreviation:,9-CRA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Acronym:,9-cis-RA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,ALRT1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,LGD1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid"
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP3026
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP-3026
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Chemical structure:,"N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB 1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB-1003
2020-09-18T01:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-ro5424802,Code name:,RO5424802
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Synonym:,FL-006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL 006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX 0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX-0593
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ B3139
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ-B3139
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT 707
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT-707
2020-09-18T01:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-trk-inhibitor-tsr-011,Code name:,TSR-011
2020-09-18T01:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-potassium-bicarbonate-anhydrous-citric-acid,US brand name:,Alka Seltzer Gold
2020-09-18T01:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/708408,US brand name:,Alkagin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,alanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysine
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,sarcoclorin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,US brand name:,Alkeran
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Melphalanum
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Sarkolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Abbreviation:,L-PAM
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,CB-3025
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,WR-19813
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Chemical structure:,4-[bis(2-chloroethyl)amino]-L-phenylalaninep-di(chloroethyl)amino-L-phenylalanine
2020-09-18T01:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-inhibitor-cep-37440,Code name:,CEP-37440
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG 0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG-0418
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,alkylglycerol and rosemary capsules
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,rosemary/alkylglycerol dietary supplement
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,Synonym:,fexofenadine HCl
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,US brand name:,Allegra
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,AllerNaze
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Aristocort A
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Kenalog
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Nasacort
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,Chemical structure:,"9-alpha-fluoro-11-beta,21-dihydroxy-16-alpha-isopropylidenedioxy-1,4-pregnadiene,3,20-dione"
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific TR1 cells Allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific type 1 Tregs T-allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,donor-derived host alloantigen-specific IL-10 anergized T cells
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,T-allo10 cells
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Abbreviation:,T-allo10
2020-09-18T01:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-haploidentical-t-cells-expressing-inducible-caspase-9,Synonym:,iCasp9 allogeneic T cells
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,Theralux-ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,US brand name:,Allodepleted T-cell ImmunotheRapeutics
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Code name:,ATIR101
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,ATIR
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,Theralux-ATIR
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,US brand name:,Allodepleted T-cell ImmunotheRapeutics
2020-09-18T01:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Code name:,ATIR101
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCOne
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCP-001
2020-09-18T01:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic adenovirus-specific CTLs
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived MSCs
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived stem/stromal cells
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic mesenchymal stem/stromal cells
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,ALLO-715 cells
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,alloCAR T ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,anti-BCMA allogeneic CAR T cells ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,BCMA allogeneic CAR T cells ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO 715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO-715
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic anti-BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/CS1 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA CAR T cells PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA-CAR T lymphocytes PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Code name:,PBCAR269A
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,allogeneic anti-CD19 UCAR-T cells CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,universal CD19-directed CAR-T cells CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA 101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA-101
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,allogeneic anti-CD19-CAR T lymphocytes PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,anti-CD19-CAR allogeneic T cells PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Code name:,PBCAR0191
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Synonym:,LUCAR-20S CAR-T cells
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR 20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR-20S
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Synonym:,allogeneic anti-CD20 CAR T lymphocytes PBCAR20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,BCAR20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR 20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR-20A
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,allogeneic DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,allogeneic DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribble cancer vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribbles vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRiPs and SLiPs-containing blebs vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV 001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV-001
2020-09-18T01:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-b71-hla-a1-transfected-tumor-cell-vaccine,NA,NA
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,allogeneic engineered T cells expressing anti-CD123 chimeric antigen receptor
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,UCART123 T cells
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cell 123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cells targeting CD123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal TALEN gene-edited CART123 cells
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Code name:,UCART123
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,allogeneic CARCIK-CD19 cells
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,transposon-manipulated allogeneic CARCIK-CD19 cells
2020-09-18T01:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717909,Synonym:,allogeneic CD19CAR-TCM cells
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,US brand name:,haNK
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,TCR/CD52-deficient RQR8+ CD19-CAR+ T cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART19 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal chimeric antigen receptor T cell 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal TALEN gene-edited CART19 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,ALLO-501
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,S68587
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory natural killer cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory NKs cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive NK cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,NKG2C/CD57-expressing adaptive memory natural killer cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE-NK100
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted PBSCs
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted peripheral blood stem cells
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted PBSCs
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted peripheral blood stem cells
2020-09-18T01:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/580835,Foreign brand name:,AlloStim
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI 001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI-001
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic CMV-specific antigen-selected T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T lymphocytes
2020-09-18T01:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-adv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR CRISPR-edited T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR-T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9 gene-editing CD19-directed CAR T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9-engineered anti-CD19 CAR T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX 110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX101
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX-110
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic TALEN gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogenic engineered T cells expressing anti- CS1 CAR UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,UCARTCS1A cells
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART CS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART-CS1A
2020-09-18T01:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cytomegalovirus-specific-cytotoxic-t-lymphocytes,Abbreviation:,allogeneic CMV-specific CTLs
2020-09-18T01:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-vaccine-combig-dc,Synonym:,COMBIG-DC
2020-09-18T01:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-myeloma-idiotype-vaccine,NA,NA
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Synonym:,allogeneic DNT cells
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Code name:,DNT-UHN-1
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urosin
2020-09-18T01:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV-specific CTL
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,allogeneic glial restricted progenitor cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,Q-cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Abbreviation:,GRPs
2020-09-18T01:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756037,NA,NA
2020-09-18T01:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine,Abbreviation:,GM-CSF BREAST VAC
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1 breast cancer cell line vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR1-GM breast cancer vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,US brand name:,Bria-IMT
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,GVAX allogeneic irradiated pancreatic tumor cell vaccine
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,irradiated allogeneic GM-CSF-secreting pancreatic tumor cell vaccine
2020-09-18T01:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-lethally-irradiated-whole-melanoma-cell-vaccine,Synonym:,GVAX melanoma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GM-CSF-secreting multiple myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GVAX myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic myeloma vaccine with GM-CSF-secreting K562 cells
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,GVAX allogeneic myeloma vaccine
2020-09-18T01:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-1005-pcdna-1-gm-neo,Synonym:,PANC 10.05 pcDNA-1/GM-Neo
2020-09-18T01:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-603-pcdna-1-gm-neo,Synonym:,PANC 6.03 pcDNA-1/GM-Neo
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic GM-CSF-based myeloma cell vaccine
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic granulocyte macrophage colony-stimulating factor-transfected myeloma cell vaccine
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T lymphocytes
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-specific T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic human adenovirus-specific T lymphocytes
2020-09-18T01:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hla-a2-4-1bb-ligand-expressing-melanoma-vaccine,NA,NA
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Synonym:,allogeneic HPV-specific immune lymphocytes
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Abbreviation:,allogeneic HPV-CTLs
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,allogeneic iC9/CAR19/IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,CAR-CD19-CD28-zeta-2A-iCasp9-IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR19/IL15-transduced CB-NKs
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR-CD19-CD28-zeta-2A/IL-15 CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,UCB-derived CAR-CD19-CD28-zeta-2A-iCasp9-IL15 engineered NK cells
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Synonym:,cytotoxic T lymphocytes GRm13Z40-2
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Code name:,GRm13Z40-2
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17+ CD8 T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17-producing CD8+ T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic Tc17 cells
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF 470 vaccine
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF470 vaccine
2020-09-18T01:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine,Synonym:,allogeneic LMI breast cancer vaccine
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Synonym:,allogeneic LMI melanoma vaccine LP2307
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Code name:,LP2307
2020-09-18T01:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T01:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-melanoma-vaccine-agi-101h,Code name:,AGI-101H
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,ethiofos
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,allogeneic mesothelioma tumor lysate-pulsed autologous DC vaccine
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,MesoCancerVac
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus Specific CTLs
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus-specific T cells
2020-09-18T01:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multipotent-adult-progenitor-cells,US brand name:,MultiStem
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV/CMV/AdV/HHV6/BKV-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic multivirus-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched virus-specific T cells
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched VST
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Abbreviation:,allogeneic NK cell line MG4101
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Code name:,MG4101
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NK cells
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NKs
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,donor nicotinamide-expanded natural killer cells
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Synonym:,allogeneic NKG2DL-targeting CAR-gd T cells
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Code name:,CTM-N2D
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,allogeneic pDCs- expressing lung tumor antigens PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,therapeutic cancer vaccine PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDClung01
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Synonym:,IL-7/GM-CSF/CD80/CD154-encoding synthetic dSLIM-30L1 allogeneic renal cell carcinoma vaccine MGN1601
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Code name:,MGN1601
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,allogeneic NY-ESO-1-c259 T cells
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,NY-ESO-1 c259 T cells
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR a/b T cell-depleted PBSCs
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR alpha/beta T cell-depleted PBSCs
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Abbreviation:,CTL 19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL-19
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR SILK cells
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK cells
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Synonym:,Allogenic Cell Vaccine
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Abbreviation:,ALLOTCV
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Synonym:,allogeneic UCB-derived hematopoietic stem and progenitor cells NLA101
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Code name:,NLA101
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,sodium allopurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Aloprim
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Lopurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zyloprim
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Adenock
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allo-Puren
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allozym
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allural
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Aloral
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apulonga
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Caplenal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cellidrin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cosuric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Dabroson
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Gichtex
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hamarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hexanurat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketanrift
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ledopur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Lysuron
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Miniplanor
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Monarch
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Nektrohan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Remid
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Riball
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Sigapurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Suspendol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Takanarumin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uripurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urosin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urtias
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Abbreviation:,4'-HPP
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW 56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW-56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Chemical structure:,"1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt4-hydroxypyrazolo[3,4-d]pyrimidine"
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,EGFR/HER2 inhibitor BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,ErbB mutant-specific inhibitor BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX 189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX-189
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,n-muramyldipeptide derivative
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,norMDP
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,nor-MDP
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Code name:,Cgp-11637
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Chemical structure:,N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Synonym:,vinorelbine liposomes injection
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,US brand name:,Alocrest
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Acronym:,VLI
2020-09-18T01:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-gel,NA,NA
2020-09-18T01:56:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796,US brand name:,Alantel
2020-09-18T01:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751302,NA,NA
2020-09-18T01:56:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alogliptin,Chemical structure:,"benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl]methyl]-"
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Alositol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anoprolin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anzief
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Apurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bleminol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bloxanth
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Embarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Epidropal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Folligan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Geapur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Ketobun-A
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,sodium allopurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urbol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Uricemil
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urosin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Xanturat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Zyloric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Aloprim
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Lopurin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zyloprim
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Adenock
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allo-Puren
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allozym
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allural
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Aloral
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Alositol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anoprolin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anzief
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apulonga
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bleminol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bloxanth
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Caplenal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cellidrin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cosuric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Dabroson
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Embarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Epidropal
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Folligan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Geapur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Gichtex
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hamarin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hexanurat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketanrift
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketobun-A
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ledopur
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Lysuron
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Miniplanor
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Monarch
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Nektrohan
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Remid
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Riball
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Sigapurol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Suspendol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Takanarumin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urbol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uricemil
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uripurinol
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urosin
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urtias
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Xanturat
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Zyloric
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Abbreviation:,4'-HPP
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW 56158
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW-56158
2020-09-18T01:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Chemical structure:,"1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt4-hydroxypyrazolo[3,4-d]pyrimidine"
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,US brand name:,Aloxi
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Code name:,RS 25259-197
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Chemical structure:,"1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride,(3aS)-"
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,phosphoinositide 3-kinase inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,PI3K inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,US brand name:,Piqray
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Code name:,BYL719
2020-09-18T01:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-adenoviral-vector-vaccine,Abbreviation:,AdVhAFP
2020-09-18T01:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-plasmid-dna-vaccine,Abbreviation:,phAFP
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,aGal AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,anti-alpha Gal immunotherapeutic AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI 134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI-134
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell and CD19+ B-cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs
2020-09-18T01:57:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/539100,US brand name:,HyperAcute-Lung Cancer Vaccine
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,US brand name:,HyperAcute™ Renal
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,Abbreviation:,HAR
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha 1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1-antiproteinase
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Aralast
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Prolastin-C
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1AT
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1P1
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,AAT
2020-09-18T01:57:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,AFP peptide-pulsed autologous dendritic cell vaccine
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Synonym:,BGC 945
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX 0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX-0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Chemical structure:,"N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid"
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Synonym:,"galactose(alpha1,3,)galactose glycosphingolipids"
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Abbreviation:,GSL alpha-GAL
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Synonym:,KRN7000-pulsed autologous dendritic cells
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Abbreviation:,DC-KRN7000
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,Synonym:,"6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1)"
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,US brand name:,Alphagan
2020-09-18T01:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid,Synonym:,thioctic acid
2020-09-18T01:57:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802261,Foreign brand name:,Opera
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Synonym:,palladium lipoic complex
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,US brand name:,PolyMVA
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Abbreviation:,LAPd
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,a-methyl-4[18F]-4-deoxy-D-glucopyranoside
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,Me-4(18F)DG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me-4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Chemical structure:,alpha-methyl-4-[F-18]-fluoro-4-deoxy-d-glucopyranosidealpha-methyl-4-deoxy-4-(18F)fluoro-D-glucopyranoside
2020-09-18T01:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopherol,Chemical structure:,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol"
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Abbreviation:,α-TEA
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Chemical structure:,"2,5,7,8-tetramethyl-(2R-(4R,8R,12-trimethyltridecyl) chroman-6-yloxy) acetic acid"
2020-09-18T01:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-type-1-polarized-dendritic-cells,Abbreviation:,alphaDC1
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,US brand name:,Xanax
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Apo-Alpzar
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Nu-Alpraz
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Synonym:,prostaglandin E1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,Caverject
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,MUSE
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Abbreviation:,PGE1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Chemical structure:,"(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid"
2020-09-18T01:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramipril,US brand name:,Altace
2020-09-18T01:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altiratinib,Code name:,DCC-2701
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hemel
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hexaloids
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,Hexalen
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,hexamethylmelamine
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexastat
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexinawas
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HMM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HXM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,ENT-50852
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,RB-1515
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,WR-95704
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Chemical structure:,"2,4,6-tris(dimethylamino)-s-triazineN,N,N',N',N"",N""-hexamethyl-1,3,5-triazine-2,4,6-triamine"
2020-09-18T01:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide,NA,NA
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Synonym:,dual ALK/EGFR inhibitor AP26113
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,US brand name:,Alunbrig
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Code name:,AP26113
2020-09-18T01:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-therapeutic-vaccine,NA,NA
2020-09-18T01:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-ny-eso-1-m-tricom-vaccine,Code name:,vCP2292
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Synonym:,ALVAC-CEA
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Abbreviation:,ALVAC-CEA
2020-09-18T01:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-eso-1-vaccine,NA,NA
2020-09-18T01:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-hb71,NA,NA
2020-09-18T01:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-mart-1-vaccine,NA,NA
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD 9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD-9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,MPH-966
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Chemical structure:,"6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide"
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Abbreviation:,17-DMAG HCL
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,BMS-826476
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,KOS-1022
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Chemical structure:,"geldanamycin,17-demethoxy-17-[[2-(dimethylamino)ethyl]amino]-,monohydrochloride"
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,US brand name:,Entereg
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,ADL8-2698
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,LY-246376
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Synonym:,flavopiridol
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Abbreviation:,FLAVO
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,HMR 1275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,L-868275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Chemical structure:,"(-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one hydrochloride"
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate TP-1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP 1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP-1287
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,Synonym:,Amantadine HCl
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symadine
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symmetrel
2020-09-18T02:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glimepiride,US brand name:,Amaryl
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Synonym:,anti-mesothelin monoclonal antibody MORAb-009
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Code name:,MORAb-009
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,US brand name:,Ambien
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,Abbreviation:,ZPD
2020-09-18T02:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792680,NA,NA
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,US brand name:,Amdray
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Code name:,PSC 833
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Chemical structure:,"6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]cyclosporin Dcyclo((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-me"
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,aminolevulinic acid HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,amino-levulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,delta-aminolevulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Levulan Kerastick
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Foreign brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,5-ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Chemical structure:,5-amino-4-oxopentanoic acid HCl5-Amino-4-oxopentanoic Acid Hydrochlorided-Amino-Levulinic Acid HCl
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,depot-medroxyprogestereone acetate
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,metipregnone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Amen
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Depo-Provera
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Provera
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Aragest
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Ciclotal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinofem
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Depo-Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Gestapuran
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,G-Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Hysron
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Lutoral
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Perlutex
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Prodasone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Sodelut G
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Veramix
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Abbreviation:,MPA
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Chemical structure:,"(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione17-(acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione17alpha-acetoxy-6alpha-methylprogesterone17-hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate6-alpha-methyl-17alpha-acetoxyprogesterone"
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax ginseng
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax quinquifolius
2020-09-18T02:00:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,US brand name:,Amevive
2020-09-18T02:00:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,Code name:,LFA3TIP
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Amfebutamone
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Forfivo XL
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Wellbutrin
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Zyban
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Code name:,BW 323U66
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Chemical structure:,"(+-)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride"
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminocaproic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminohexanoic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,epsilon S
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,US brand name:,Amicar
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,US brand name:,Firdapse
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,Chemical structure:,"3,4-diaminopyridine"
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,amifostine trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,aminopropylaminoethylthiophosphoric acid trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,US brand name:,Ethyol
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Foreign brand name:,Cytofos
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Abbreviation:,APAETP
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR 2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR-2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,YM-08310
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Chemical structure:,2-[(3-aminopropyl)amino]ethanethiol dihydrogen phosphate ester trihydrateS-(N-(3-aminopropyl)-2-aminoethyl)thiophosphoric acid trihydrateS-2-(3-aminopropylamino)ethylphosphorothioic acid trihydrate
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41 6551
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41-6551
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,Synonym:,multi-amino acid injection
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,US brand name:,Travasol
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,amino acid/electrolyte-coupled transport supplement
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,proprietary amino acid mixture
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,US brand name:,Enterade
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,Potaba
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium p-aminobenzoate
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium para-aminobenzoate
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-aminocamptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-camptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-CPT
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Abbreviation:,9-AC
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Chemical structure:,9-amino-20(S)-camptothecin9-amino-20-camptothecin
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminocaproic acid
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminohexanoic acid
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,epsilon S
2020-09-18T02:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,US brand name:,Amicar
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolaevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,amino-levulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta-aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Abbreviation:,5-ALA
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Chemical structure:,5-amino-4-oxopentanoic acidd-amino-levulinic acid
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,aminolevulinic acid HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,amino-levulinic acid hydrochloride
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,delta-aminolevulinic acid hydrochloride
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Ameluz
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Levulan Kerastick
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Foreign brand name:,Ameluz
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,5-ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,ALA HCl
2020-09-18T02:01:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Chemical structure:,5-amino-4-oxopentanoic acid HCl5-Amino-4-oxopentanoic Acid Hydrochlorided-Amino-Levulinic Acid HCl
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,ammophyllin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,theophyline ethylenediamine
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Phyllocontin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Truphylline
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Chemical structure:,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-Ethanediamine(2:1)"
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminofolic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminopteroylglutamic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopterin aodium
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopteroylglutamic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Abbreviation:,APGA
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,2-Aminothiadiazole
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,Amino 134-Thiadiazole
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,A-TD
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,ATDA
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Code name:,FDA 0084
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Chemical structure:,"1,3, 4-Thiadiazol-2-amine (9CI)1,3, 4-Thiadiazole, 2-Amino- (8CI)1,3,4-Thiadiazole, 2-Amino2-Amino-1,3,4-thiadiazole2-Amino-1-thia-3,4-diazole"
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Cordarone
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Nexterone
2020-09-18T02:02:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lubiprostone,US brand name:,Amitiza
2020-09-18T02:02:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amitriptyline-hydrochloride,NA,NA
2020-09-18T02:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-plus-lysate-loaded-autologous-dendritic-cell-vaccine,Synonym:,acute myelogenous leukemia mRNA plus lysate loaded autologous dendritic cell vaccine
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,8-methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,Methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Ammoidin
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen-Ultra
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Uvadex
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Xanthotoxin
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Deltasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Dermox
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geroxalen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinina
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinine
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Metoxaleno
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Mopsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Puvasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Ultramop
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Abbreviation:,8-MOP
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Chemical structure:,"9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one"
2020-09-18T02:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonia-n-13,Synonym:,ammonia-(sup 13)N
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,US brand name:,Ossirene
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,AS-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,IVX-Q-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Chemical structure:,"tellurate(1-), trichloro[1,2-ethanediolato(2-)-.kappa.O,.kappa.O']-,ammonium, (SP-5-22)-"
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,US brand name:,AmnioFix
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,Abbreviation:,dHACM
2020-09-18T02:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amnion-derived-cellular-cytokine-solution,Abbreviation:,ACCS
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Synonym:,(+-)-zopiclone
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,US brand name:,Amoban
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Code name:,RP 27267
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Chemical structure:,"1-piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine"
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide hydrochloride
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,benzisoquinolinedione
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,nafidimide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,US brand name:,Quinamed
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,AMON
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,BIDA
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Code name:,M-FA-142
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Chemical structure:,"1H-benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)"
2020-09-18T02:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-l-malate,NA,NA
2020-09-18T02:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792531,Abbreviation:,ACC
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Amoxil
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Polymox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Trimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Utimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Wymox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,Abbreviation:,AMOX
2020-09-18T02:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin-clavulanate-potassium,US brand name:,Augmentin
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Amoxil
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Polymox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Trimox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Utimox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Wymox
2020-09-18T02:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,Abbreviation:,AMOX
2020-09-18T02:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amphotericin-b-deoxycholate,US brand name:,Fungizone
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Synonym:,Teturamin
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,US brand name:,Antabuse
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,DS
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,TTD
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Chemical structure:,bis(diethylthiocarbamoyl) disulfidetetraethylthioperoxydicarbonic diamidetetraethylthiuram disulfide
2020-09-18T02:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ampicillin-sodium-sulbactam-sodium,US brand name:,Unasyn
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Synonym:,atvogen
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,US brand name:,Ampligen
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Abbreviation:,poly(I):poly(C12U) RNA
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Chemical structure:,"poly(inosinic acid) poly(cytidylic(12), uridylic)acid"
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,US brand name:,Amplimexon
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,Chemical structure:,"4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one"
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Synonym:,Amirubicin Hydrochloride
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Foreign brand name:,Calsed
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Abbreviation:,AMR
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,acridinyl anisidide
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,Cain's Acridine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,US brand name:,Amsa P-D
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amekrin
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidyl
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Lamasine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,m-AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,CI-880
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,SN-11841
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Chemical structure:,4'-(9-acridinylamino)methane-sulfon-m-anisidideN-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,acridinyl anisidide
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,Cain's Acridine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,US brand name:,Amsa P-D
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amekrin
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidyl
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Lamasine
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,AMSA
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,m-AMSA
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,CI-880
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,SN-11841
2020-09-18T02:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Chemical structure:,4'-(9-acridinylamino)methane-sulfon-m-anisidideN-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC 101
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC-101
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Synonym:,multitargeted receptor tyrosine kinase inhibitor MP470
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,HPK56
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,MP470
2020-09-18T02:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,US brand name:,Agrylin
2020-09-18T02:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,Foreign brand name:,Thromboreductin
2020-09-18T02:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-prolonged-release-formulation,Synonym:,anagrelide retard
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,IL-1ra
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,interleukin-1 receptor antagonist
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,US brand name:,Kineret
2020-09-18T02:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anamorelin-hydrochloride,Code name:,RC-1291
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,US brand name:,Arimidex
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Abbreviation:,ANAS
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI-D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ZD-1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Chemical structure:,"2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile"
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Synonym:,triglycidylurazol
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Abbreviation:,TGU
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Chemical structure:,"1,2,4-triglycidylurazol"
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Ancef
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Kefzol
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Code name:,SKF 41558
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Chemical structure:,"(6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,Cyclo-C
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cycloCMP hydrochloride
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine HCL
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine hydrochloride
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Foreign brand name:,Ancid
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Code name:,"U-33, 624A"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Chemical structure:,"6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R(2alpha,3beta,3a beta,9a beta))"
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Synonym:,5-fluorocytosine
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,US brand name:,Ancobon
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Alcobon
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Ancotil
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Abbreviation:,5-FC
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro 2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro-2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Chemical structure:,4-amino-5-fluoro-2(1H)-pyrimidinone
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Andro LA
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Delatestryl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Everone
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Primosteston
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Testate
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Androtardyl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testinon
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testo-Enant
2020-09-18T02:05:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-gel,US brand name:,AndroGel
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Code name:,APC-100
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Chemical structure:,"pentamethylchromanol, 2,2,5,7,8-pentamethyl-6"
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Synonym:,AR antagonist BAY 1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY 1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY-1161116
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Synonym:,AR antagonist ONC1-0013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 113 B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-0013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC-10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC113B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-13B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Chemical structure:,"(R)-4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]nonan-1-yl)-2-fluoro-N-methylbenzamide"
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR 3680
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR3680
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,androgen receptor inhibitor TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,AR antagonist TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS 3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS3681
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Synonym:,AR antagonist TRC253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ 63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ -63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC 253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC-253
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-ARRx
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-AZ1Rx
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Code name:,AZD5312
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist LNA antisense oligonucleotide EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist locked nucleic acid antisense oligonucleotide EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Code name:,EZN-4176
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,androgen receptor PROTAC degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR PROTAC ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR-targeted PROTAC protein degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,PROTAC protein degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV 110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV-110
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Synonym:,AR degrader CC-94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC 94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC-94676
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Synonym:,AR inhibitor EPI-506
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Code name:,EPI-506
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Synonym:,AR inhibitor EPI-7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI 7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI-7386
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,AR LBD-encoding plasmid DNA vaccine MVI-118
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR vaccine
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Code name:,MVI-118
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Synonym:,AR/GR antagonist CB-03-10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB 03 10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB0310
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB-03-10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Chemical structure:,cortexolone 17alpha-valerate-21-propionate
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androfluorene
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androsterolo
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Android-F
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halodrin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halotestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ora-Testryl
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ultandren
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Oratestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Stenox
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Testoral
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Abbreviation:,FXM
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Chemical structure:,"(11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone"
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,US brand name:,APOTONE
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,Chemical structure:,"17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol"
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Synonym:,Suxamethonium Chloride
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Anectine
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Quelicin
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Chemical structure:,"Ethanaminium, 2,2'-((1,4-Dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-)"
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Synonym:,anti-mesothelin antibody-drug conjugate BAY 94-9343
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Code name:,BAY 94-9343
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Synonym:,MFMT OMN54
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,US brand name:,Aneustat
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Code name:,OMN54
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,PEG G-CSF ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,pegfilgrastim ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,US brand name:,ANF-Rho
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,CVX-241
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,PF-05057459
2020-09-18T02:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angelica-sinensis-root-extract,Synonym:,dong quai
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Synonym:,pegylated anti-VEGF anticalin PRS-050-PEG40
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,US brand name:,Angiocal
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Code name:,PRS-050-PEG40
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Synonym:,VEGFR-2 inhibitor peptide CT-322
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,US brand name:,Angiocept
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Code name:,CT-322
2020-09-18T02:07:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-ji-101,Code name:,JI-101
2020-09-18T02:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-heparanase-inhibitor-pg545,Code name:,PG545
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,Kringles 1-4 of Plasminogen
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,PLG
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,US brand name:,Angiozyme
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Foreign brand name:,Angiozyme
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Code name:,RPI.4610
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,Anguidin
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,diacetoxyscirpenol
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Abbreviation:,DAS
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Code name:,MM 4462
2020-09-18T02:08:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800694,Abbreviation:,AEO
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,V-echinocandin
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,VER-002
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,US brand name:,Eraxis
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Foreign brand name:,Eraxis
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Code name:,LY303366
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphochin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphocin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphoquin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,mesylerythrol
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,A 14489
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,CB 1074
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,SK 592
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,TL 476
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Chemical structure:,"benzenamine, N, N-bis(2-chloroethyl)-(9CI)beta, beta'-dichlorodiethylanilineN,N-bis(2-chloroethyl)anilineN,N-bis(2-chloroethyl)benzenaminephenylbis[2-chloroethylamine]"
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Synonym:,"1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, dihydrochloride"
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Abbreviation:,ALTN HCl
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Chemical structure:,"cyclopropanamine, 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-, hydrochloride (1:2)"
2020-09-18T02:08:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annonaceous-acetogenins,Synonym:,acetogenins
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,US brand name:,Ansaid
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"BTS 18,322"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,E-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,MPC-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"U-27,182"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Chemical structure:,"2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid"
2020-09-18T02:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthocyanin-rich-corn-extract,NA,NA
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Code name:,GPX-150
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Chemical structure:,5-imino-13-deoxydoxoubicin
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Abbreviation:,anti c-KIT ADC LOP628
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Code name:,LOP628
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted antibody-drug conjugate ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted dolaflexin ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,anti-5T4 ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN 004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN-004
2020-09-18T02:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-pf-06263507,Code name:,PF-06263507
2020-09-18T02:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a33-monoclonal-antibody-krn330,Code name:,KRN330
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Synonym:,anti-alpha5beta1 integrin monoclonal antibody PF-04605412
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Code name:,PF-04605412
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,anti-ACTR viral vector-transduced autologous T lymphocytes ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,CD16-41BB-CD3zeta ACTR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,viral ATCR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,virally-delivered antibody-coupled TCR ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR-087
2020-09-18T02:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-16-monoclonal-antibody-ags-16m18,Code name:,AGS-16M18
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Abbreviation:,anti-AGS-5 Ab-drug conjugate ASG-5ME
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Code name:,ASG-5ME
2020-09-18T02:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-8-monoclonal-antibody-ags-8m4,Code name:,AGS-8M4
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Synonym:,anti-activin receptor-like kinase 1 monoclonal antibody PF-03446962
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Code name:,PF-03446962
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-BsAb TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-cell engaging bispecific antibody TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB 383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB-383B
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,anti-AMHR2 monoclonal antibody GM10II
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,GM102 antibody
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,3C23K
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM102
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM10II
2020-09-18T02:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amyloid-monoclonal-antibody-neod001,Code name:,NEOD001
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL 01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL-01
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MoAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Code name:,MEDI-3617
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Foreign brand name:,Hamsa-1
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Code name:,TL-118
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-A proliferation-inducing ligand monoclonal antibody BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-TNFSF13 monoclonal antibody BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Code name:,BION-1301
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Synonym:,AXL Fc fusion protein AVB-S6-500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB S6 500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVBS6500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB-S6-500
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE ADC
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE antibody-drug conjugate
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Abbreviation:,HuMax-AXL-ADC
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,ADC ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,anti-AXL/PBD ADC ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB-601
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,anti-B4 blocked ricin
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,monoclonal antibody anti-B4 blocked ricin
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,anti-B4-BR
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,MOAB anti-B4-bR
2020-09-18T02:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-antibody-ds-5573a,Code name:,DS-5573a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7-H3/DXd ADC DS-7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7H3/DXd antibody-drug conjugate DS-7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300a
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA 150
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA 150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA-150
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Synonym:,Anti-BCMA Afucosylated Monoclonal Antibody SEA-BCMA
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Code name:,SEA-BCMA
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,anti-TAG ARC-T cells directed by BCMA bi-valent/TAG SparX protein
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,ARC-T plus anti-BCMA SparX
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,immunotherapeutic combination agent SparX protein plus CART-ddBCMA
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,TAG-containing SparX /bivalent BCMA-targeted ARC-T cells
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA x anti-CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA/CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-CD3/anti-BCMA bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN 5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN-5459
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BiTE antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG-420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI 836909
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI836909
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BiTE antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG-701
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,anti-BCMA x anti-CD3 BiTE REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,bispecific BCMA x CD3 T-cell engaging antibody REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,BiTE antibody REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN 5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN-5458
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,anti-BCMA ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Anti-BCMA/PBD MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Antibody-drug Conjugate MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI 2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI-2228
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Code name:,SQ109
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Chemical structure:,"N-geranyl-N?-(2-adamantyl) ethane-1,2-diamine"
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV-011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC-011
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Synonym:,ADC ABBV-085
2020-09-18T02:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793089,Code name:,YS110
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Code name:,ABBV-085
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Synonym:,ADC ABBV-155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV 155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV-155
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Synonym:,ADC ABBV-176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV 176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV-176
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT 1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT-1536
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC anti-TIM-1-vcMMAE CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,antibody-drug conjugate CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vcMMAE
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vc-MMAE
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Code name:,CDX-014
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,ADC BAY79-4620
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,MN-IC
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Code name:,BAY79-4620
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Synonym:,ADC DFRF4539A
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Code name:,DFRF4539A
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Synonym:,ADC MEDI7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI 7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI7247
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Synonym:,ADC SC-002
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Code name:,SC-002
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Synonym:,ADC SC-003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC 003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC-003
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Synonym:,ADC SC-004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC 004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC-004
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,ADC SC-005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC 005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC-005
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Synonym:,ADC SC-006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC 006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC-006
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,ADC SC-007
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,SC-007
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,CD95-Fc fusion protein CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,Fas-Fc fusion protein CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG-101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN-008
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Synonym:,anti-B- and T-lymphocyte attenuator monoclonal antibody TAB004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS-004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB-004
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Abbreviation:,anti-C4.4a ADC BAY1129980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY1129980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY112-9980
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Synonym:,anti-C5aR-215
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH 5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,NN 8210
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab 5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab-5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,MVT-5873
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Abbreviation:,huDs6-DM4
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Code name:,SAR566658
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Synonym:,anti-catabolic/anabolic transforming agent MT-102
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Code name:,MT-102
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,antibody-drug conjugate IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,CD123-targeted ADC IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN 632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN-632
2020-09-18T02:13:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-monoclonal-antibody-khk2823,Code name:,KHK2823
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Synonym:,anti-CD123/anti-CD3 bispecific antibody XmAb1404
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Code name:,XmAb14045
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,anti-CD123 x anti-CD3 bispecific antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,bispecific anti-CD123 x anti-CD3 antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,CD123 x CD3 targeting bispecific antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO 436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO-436
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Synonym:,humanized CD123 x CD3 duobody JNJ-63709178
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Code name:,JNJ-63709178
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,bispecific T-cell engager antibody SAR440234
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,CD123xCD3 bispecific T-cell engager SAR440234
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,antibody-drug conjugate SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123 ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123-PBD ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN-CD123A
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT312
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic anti-CD133 CAR T cells
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic CART133
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,anti-CD133-deimmunized pseudomonas exotoxin A-KDEL fusion protein
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL toxin
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,dCD133KDEL
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,4-1BB-directed agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,anti-4-1BB agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,CD137-directed agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG 106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG-106
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-4-1BB agonistic monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 agonist monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN 2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN-2373
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-4-1BB monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 agonist monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR 1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR-1017
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Synonym:,anti-4-1BB agonistic monoclonal antibody CTX-471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX 471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX-471
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-4-1BB agonistic monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 agonist monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 monoclona antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN 6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN-6051
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,MEN1112
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,OBT357NF
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,ADC CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,anti-CD166-DM4 CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,PDC CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Code name:,CX-2009
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 AbTCR-expressing T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19-TCR T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,CD19-targeted T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,ET019003-T cells
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET 019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET-019003
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Synonym:,CD19-specific CAR-T cells XLCART001
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Code name:,XLCART001
2020-09-18T02:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-fully-human-monoclonal-antibody-mdx-1342,Code name:,MDX-1342
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Synonym:,anti-CD19 MoAb DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Abbreviation:,anti-CD19 MAb DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Code name:,DI-B4
2020-09-18T02:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-medi-551,Code name:,MEDI-551
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,anti-CD19/CD20/CD22/CD30 chimeric antigen receptor-T cells
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,CAR-T CD19/CD20/CD22/CD30
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Synonym:,anti-CD19/CD22 BLT DT2219ARL
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Code name:,DT2219ARL
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,BiTE antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,CD19/CD3-directed bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG-562
2020-09-18T02:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-tetravalent-antibody-afm11,Code name:,AFM11
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,FMC63-28Z CAR-transduced allogeneic T lymphocytes
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,MSGV1-FMC63-28Z anti-CD19 CAR-transduced allogeneic T lymphocytes
2020-09-18T02:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-retroviral-vector-transduced-autologous-t-cells,NA,NA
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,autologous CAR-19/CAR-20-T cells Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,Hu1928-Hu20BB
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19 redirected NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing allogenic NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor natural killer cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Code name:,NKCARCD19
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,autologous CAR-20/19-T cells
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Synonym:,anti-CD19/CD28/zeta modified CAR CD3+ T lymphocytes JCAR015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 15
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR015
2020-09-18T02:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-dm4-immunoconjugate-sar3419,Code name:,SAR3419
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9 scFv-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,recombinant anti-CD20 B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,scFv B9E9-streptavidin fusion protein
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B 001
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B001
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT 4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT-4306F
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL 62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL-62
2020-09-18T02:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-sct400,Code name:,SCT400
2020-09-18T02:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-tl011,Code name:,TL011
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Synonym:,anti-CD20 monoclonal antibody-IFN-a fusion protein IGN002
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Code name:,IGN002
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific CD20xCD3 IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,IgM pentamer IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM 2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM-2323
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody REGN1979
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Code name:,REGN1979
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody XmAb13676
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Code name:,XmAb13676
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,ADC OBT076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,Anti-CD205
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN 1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN-1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT 076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT-076
2020-09-18T02:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,NA,NA
2020-09-18T02:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-engineered-toxin-body-mt-3724,Code name:,MT-3724
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22 antibody-drug conjugate TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22-4AP ADC TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,CAT-02-106
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH 222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH-222
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Synonym:,anti-CD22 CAR-expressing T cells
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Abbreviation:,CD22 CAR-T
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,ADC DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,antibody-drug conjugate DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Code name:,DCDT2980S
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 CARs-expressing tandem TCR-zeta/4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 chimeric antigen receptors expressing tandem TCR-zeta and 4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRzeta/4-1BB CART22 cells
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRζ/4-1BB CART22 cells
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228 Antibody-drug Conjugate SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228-MMAE ADC SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,anti-melanotransferrin ADC SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGN CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGNCD228A
2020-09-18T02:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767368,Synonym:,anti-CD22-CAR m971-BBz cells
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,anti-CD25 monoclonal antibody RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,T-regulatory cell-depleting antibody RO7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG 6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG-6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO 7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO-7296682
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Synonym:,anti-epithelial cell adhesion molecule /anti-CD3 antibody-drug conjugate AMG 172
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Code name:,AMG 172
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,A-dmDT390-bisFv(UCHT1) fusion protein
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,anti-T cell immunotoxin A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,US brand name:,Resimmune
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Abbreviation:,A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Synonym:,CD20Bi-armed activated T cells
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Abbreviation:,anti-CD3 x anti-CD20 bi-armed ATC
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Synonym:,duobody-CD3x5T4
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN 1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN-1044
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 bispecific antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 duobody antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,humanized BCMA/CD3 duobody antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ 64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ64007957
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,anti-CD3/anti-BCMA bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,B-cell maturation antigen-CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA x CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA-CD3 bispecific Ab PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF 06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF-06863135
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Synonym:,Bi20
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Code name:,FBTA05
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 bispecific antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D/CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,humanized GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ 64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ-64407564
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-CD3 x anti-GUCY2C bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-GUCY2C/anti-CD3 bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,T-cell bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF 07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF-07062119
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,US brand name:,DuoBody-CD3xCD20
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN 3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN-3013
2020-09-18T02:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793935,NA,NA
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,anti-CD3/CD7-RTA immunotoxin
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,CD3/CD7-ricin A IT
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,US brand name:,T-Guard
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,anti-CD3 x hu3F8 bispecific antibody-armed ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,OKT3/humanized 3F8 bispecific antibody-activated T lymphocytes
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,GD2Bi-a ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,Hu3F8Bi-armed ATC
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,anti-CD3/MUC1-armed PD-1 inhibitor-induced CIK cells
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,PD-1 activated CIK armed with anti-CD3/Anti-MUC1 bispecific antibody
2020-09-18T02:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-mdx-1401,Code name:,MDX-1401
2020-09-18T02:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-xmab2513,Code name:,XmAb2513
2020-09-18T02:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-cd16a-monoclonal-antibody-afm13,Code name:,AFM13
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,anti-CD30/DM1 ADC F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,F0002-ADC
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,FADC F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F 0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F-0002
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,anti-hFcγRIIB monoclonal antibody BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,hFcgammaRIIB mAb BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI 1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI-1206
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33 x CD3 tandem diabody AMV-564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33/CD3 TandAbs AMV564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV 564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV-564
2020-09-18T02:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-bi-836858,Code name:,BI 836858
2020-09-18T02:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-dm4-conjugate-ave9633,Code name:,AVE9633
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/anti-CD3 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/CD3 antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM-333
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Synonym:,anti-CD33/anti-CD3 bispecific antibody JNJ-67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ 67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ-67571244
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,bispecific T-cell engager antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,BiTE antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 33
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG330
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,anti-CD33 x anti-CD3 BiTE AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,BiTE antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG-673
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD dimer ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 antibody-drug conjugate SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Code name:,SGN-CD352A
2020-09-18T02:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-antibody-drug-conjugate-imgn529,Code name:,IMGN529
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,BI 836826
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,mAb 37.1
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR-T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,CAR-37 T cells
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR 442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR-442085
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Synonym:,anti-CD38 MAb TAK-079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK 079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK-079
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR03087
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR202
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,TJ202/MOR202
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T cells
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T lymphocytes
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/BCMA CAR T cells
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Synonym:,tri-specific T-cell engager SAR442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR 442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR-442257
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38 x anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38/anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,BEAT GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,CD38xCD3 BsAb GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR-1342
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,anti-CD38-targeted IgG4-attenuated interferon alpha TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,CD38-targeted IgG4 fused with attenuated IFNa
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TEV-48573
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX 030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX-030
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4 CAR T cells
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4-specific CAR T cells
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,agonistic anti-CD40 monoclonal antibody ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,anti-CD40 monoclonal antibody ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Code name:,ABBV-927
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,agonist CD40 antibody CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,anti-CD40 agonistic monoclonal antibody CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX 1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX-1140
2020-09-18T02:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4,Code name:,Chi Lob 7/4
2020-09-18T02:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-sea-cd40,Code name:,SEA-CD40
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,anti-CD40/anti-CD137 bispecific agonist monoclonal antibody GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,DuoBody-CD40x4-1BB GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT 312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT-312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN 1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN-1042
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Synonym:,Fc-fusion protein BMS986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS-986004
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RG 7356
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RO5429083
2020-09-18T02:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody,NA,NA
2020-09-18T02:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-ahn-12,Code name:,AHN-12
2020-09-18T02:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8,Abbreviation:,MOAB BC8
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,anti-CD45 BC8 antibody-streptavidin fusion protein
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,BC8 scFv4SA fusion protein
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Abbreviation:,BC8-SA
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,antibody-drug conjugate FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,anti-CD46 ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,CD46-ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR 46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR-46
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,ADC SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,anti-CD47 antibody-drug conjugate SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGNCD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN-CD47M
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO 176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO-176
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Synonym:,anti-CD47 Mab CC-90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC 90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC-90002
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Synonym:,OA3-targeted antineoplastic agent SHR-1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR 1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR-1603
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF 231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF-231
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ 011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ-011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJC4
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Synonym:,bispecific monoclonal antibody TG-1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG 1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG-1801
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Synonym:,Anti-CD48 ADC SGN-CD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGN CD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGNCD48A
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO 647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO-647
2020-09-18T02:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801681,Synonym:,anti-CD7 CAR T lymphocytes
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Abbreviation:,anti-CD70 ADC MDX-1203
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Code name:,MDX-1203
2020-09-18T02:24:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-sgn-cd70a,Code name:,SGN-CD70A
2020-09-18T02:24:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-mdx-1411,Code name:,MDX-1411
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,antibody prodrug-drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,anti-CD71 Probody/vcMMAE drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed probody therapeutic CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC-targeting CD71 CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX 2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX-2029
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS 986179
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS-986179
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI 006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI-006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPX-006
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV 930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV-930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF 373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF-373
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJD5
2020-09-18T02:24:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd98-monoclonal-antibody-ign523,Code name:,IGN523
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,CDH6 ADC HKT288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,maytansine-based ADC HKT-288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Abbreviation:,CDH6-ADC
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT 288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT288
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Synonym:,anti-CEA BiTE monoclonal antibody MEDI-565
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,AMG211
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MEDI-565
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MT111
2020-09-18T02:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-igcd28tcr-transduced-autologous-t-cells,NA,NA
2020-09-18T02:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-tcr-retroviral-vector-transduced-autologous-lymphocytes,NA,NA
2020-09-18T02:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-bay1179470,Code name:,BAY1179470
2020-09-18T02:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-dtpa-in-f6-734-bispecific-antibody,NA,NA
2020-09-18T02:25:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2,Synonym:,anti-CEA x anti-histamine-succinyl-glycine bispecific monoclonal antibody TF2
2020-09-18T02:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam1-monoclonal-antibody-cm-24,Code name:,CM-24
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Synonym:,ADC SAR408701
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Code name:,SAR408701
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Synonym:,immunoconjugate L-DOS47
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Code name:,L-DOS47
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY 1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY-1834942
2020-09-18T02:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-car-autologous-t-lymphocytes,Synonym:,autologous anti-CEA CAR-T cells
2020-09-18T02:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-fms-monoclonal-antibody-amg-820,Code name:,AMG 820
2020-09-18T02:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-ktn0158,Code name:,KTN0158
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Synonym:,anti-CLDN18.2 monoclonal antibody AB011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB 011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB-011
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST 001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST-001
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,ASP1650
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,IMAB027
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,anti-CLEC12A x CD3 bispecific antibody MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,bispecific antibody MCLA-117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA 117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA-117
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Synonym:,ADC HTI-1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI 1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI-1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,SHR-A1403
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,anti-c-Met ADC TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,TR1801-ADC
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT 8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT-8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR 1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR-1801
2020-09-18T02:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-abt-700,Code name:,ABT-700
2020-09-18T02:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-argx-111,Code name:,ARGX-111
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX 55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX-55
2020-09-18T02:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-ly2875358,Code name:,LY2875358
2020-09-18T02:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-sait301,Code name:,SAIT301
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Synonym:,anti–M-CSF mAb PD-0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD-0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,"PD-360,324"
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,IMC-CS4
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,LY3022855
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Synonym:,anti-M-CSFR monoclonal antibody SNDX-6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX 6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX-6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,UCB6352
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Synonym:,anti-CTLA4 antibody fusion protein KN044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN 044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN-044
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous DC
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous dendritic cell
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF-06747143
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Abbreviation:,GITRL/antiCTLA4 RNA DC
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous DC
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous dendritic cells
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG 116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG-116
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU 1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU-1604
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN 1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN-1181
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN1884
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN-1884
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Synonym:,monoclonal antibody BMS-986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS 986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS-986218
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM 4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM-4003
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK 1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK-1308
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Synonym:,anti-CTLA4 monoclonal antibody ONC-392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC 392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC-392
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN 4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN-4659
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Synonym:,probody BMS-986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS 986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS-986288
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA4/anti-PD1 monoclonal antibody combination BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA-4/PD-1 monoclonal antibody combination BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD 217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD-217
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,anti-CTLA-4/anti-LAG-3 bispecific monoclonal antibody XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,CTLA-4xLAG-3 bispecific antibody XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb 22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb-22841
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Synonym:,CTLA-4 x OX40 bispecific antibody ATOR-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR-1015
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Synonym:,anti-CXCR4 IgG1 antibody PF-06747143
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF 06747143
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Synonym:,anti-dn collagen monoclonal antibody TRC093
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,D93
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,TRC093
2020-09-18T02:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk1-monoclonal-antibody-bhq880,Code name:,BHQ880
2020-09-18T02:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk-1-monoclonal-antibody-ly2812176,Code name:,LY2812176
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,anti-DLL3 x anti-CD3 BiTE AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,BiTE antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,DLL3/CD3-directed bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG-757
2020-09-18T02:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-medi0639,Code name:,MEDI0639
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Synonym:,anti-Delta-like 4 monoclonal antibody REGN421
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Code name:,REGN421
2020-09-18T02:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-vegf-bispecific-monoclonal-antibody-omp-305b83,Code name:,OMP-305B83
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Synonym:,anti-death receptor 5 agonist monoclonal antibody TRA-8
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Code name:,TRA-8
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX 109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX-109
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Synonym:,anti-epidermal growth factor-like domain 7 monoclonal antibody MEGF0444A
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Code name:,MEGF0444A
2020-09-18T02:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797091,Synonym:,EGFR-IL12-CAR-T cells
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,ABY-029 trifluoroacetate salt
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,fluorescently-labeled Anti-EGFR affibody molecule ABY-029
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,IRDye 800CW maleimide-labeled affibody peptide
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Code name:,ABY-029
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR mAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR MoAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,mAb-806
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ 602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ-602
2020-09-18T02:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-gc1118,Code name:,GC1118
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Synonym:,cetuximab biobetter HLX07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX 07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX-07
2020-09-18T02:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-mm-151,Code name:,MM-151
2020-09-18T02:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-sym004,Code name:,sym004
2020-09-18T02:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-ro5083945,Synonym:,anti-epidermal growth factor receptor GFR monoclonal antibody RO5083945
2020-09-18T02:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-syn004,Code name:,SYN004
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Synonym:,anti-EGFR-SMCC-DM1
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Code name:,IMGN289
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-cMET/EGFR bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-EGFR/anti-c-Met bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,FIT-013a
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB 01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB-01
2020-09-18T02:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-jnj-61186372,Code name:,JNJ-61186372
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,ADC AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,antibody-drug conjugate AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Code name:,AVID100
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Synonym:,pan-HER mAb mixture Sym013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym-013
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Synonym:,anti-erbB1/erbB3 monoclonal antibody MEHD7945A
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Code name:,MEHD7945A
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,ADC ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,anti-EGFR/PBD ADC ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV 321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV-321
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Synonym:,anti-EGFRvIII-DM1 immunoconjugate AMG 595
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Code name:,AMG 595
2020-09-18T02:31:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-car-transduced-allogeneic-t-lymphocytes,Synonym:,anti-EGFRvIII CAR PG13-139-CD8-CD28BBZ-transduced T lymphocytes
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1-1KDEL
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1scFvPE38KDEL
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Code name:,MR1-1
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,anti-EGFRvIII x anti-CD3 bi-specific T-cell engager AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,bispecific BITE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,BiTE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,EGFRvIII specific BiTE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG-596
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Synonym:,anti-epithelial glycoprotein-2 immunotoxin MOC31-PE
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Code name:,MOC31-PE
2020-09-18T02:31:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endosialin-tem1-monoclonal-antibody-morab-004,Code name:,MORAb-004
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Abbreviation:,ADC AGS-16C3F
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Code name:,AGS-16C3F
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING 1
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING-1
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 antibody-targeted nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 docetaxel-based nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,EphA2-targeted docetaxel nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM 310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM-310
2020-09-18T02:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-ds-8895a,Code name:,DS-8895a
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Synonym:,1C1-mcMMAF
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Code name:,MEDI-547
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Abbreviation:,anti-EphA3 mAb KB004
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP 303c
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Code name:,KB004
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,PIK-HER2
2020-09-18T02:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb2-anti-erbb3-bispecific-monoclonal-antibody-mm-111,Code name:,MM-111
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Synonym:,anti-HER3 antibody ISU104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU 104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU-104
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Synonym:,anti-ErbB3 MoAb AV-203
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Code name:,AV-203
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-ErbB3 monoclonal antibody KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-HER3 monoclonal antibody CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN-3379
2020-09-18T02:32:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-regn1400,Code name:,REGN1400
2020-09-18T02:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-anti-igf-1r-bispecific-monoclonal-antibody-mm-141,Code name:,MM-141
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,aFAP-IL2v RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v FP RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG 7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG-7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO-6874281
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5/CD3 TDB BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 T cell-dependent bispecific antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 TDB antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,recombinant anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,RO7187797
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT 001
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT001
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Synonym:,androgen receptor antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,US brand name:,Erleada
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Abbreviation:,AR antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,JNJ-56021927
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Chemical structure:,"4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide"
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-FGFR3 ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-fibroblast growth factor receptor 3 antibody-drug conjugate LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Code name:,LY3076226
2020-09-18T02:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-mfgr1877s,Code name:,MFGR1877S
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3 1784
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3-1784
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,antiFL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITC-E2) CAR T lymphocytes
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,fluorescein-specific (FITC-E2)-CAR T cells
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,US brand name:,Angiozyme
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Foreign brand name:,Angiozyme
2020-09-18T02:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Code name:,RPI.4610
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Synonym:,FLYSYN
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Code name:,4G8-SDIEM
2020-09-18T02:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-imc-eb10,Code name:,IMC-EB10
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,anti-FLT3 x anti-CD3 BiTE AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,BiTE antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,FLT3/CD3-directed bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG-427
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRa ADC STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRalpha ADC STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO 002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO-002
2020-09-18T02:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fucosyl-gm1-monoclonal-antibody-bms-986012,Code name:,BMS-986012
2020-09-18T02:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-f901318,Code name:,F901318
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP-2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL-2397
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,inhaled antifungal PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,triazole antifungal PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC 945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC-945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Chemical structure:,"4-[4-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy}-3-methylphenyl)piperazin-1-yl]-N-(4-fluorophenyl)benzamide"
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Synonym:,anti-GM2 monoclonal antibody BIW-8962
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Code name:,BIW-8962
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Synonym:,anti-glycoprotein A repetitions predominant monoclonal antibody ABBV-151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV 151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV-151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX 115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX-115
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP303c
2020-09-18T02:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-mln0264,Code name:,MLN0264
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Synonym:,anti-GCC ADC TAK-164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK 164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK-164
2020-09-18T02:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-hu1418k322a,Code name:,hu14.18K322A
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Synonym:,anti-G-28 monoclonal antibody MORAb-028
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Code name:,MORAb-028
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,anti GD3 ADC PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,GD3 ADC PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF 06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF-06688992
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Synonym:,APCs expressing HPV16 E6/E7 SQZ-PBMC-HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ PBMC HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ-PBMC-HPV
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Synonym:,IVAC_W_bre1_uID
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Foreign brand name:,IVAC ® Warehouse vaccine
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Synonym:,GFRAL antagonistic monoclonal antibody NGM120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM 120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM-120
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Synonym:,anti-GITR agonistic monoclonal antibody PTZ-522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP 1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP-1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ 522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ-522
2020-09-18T02:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-incagn01876,Code name:,INCAGN01876
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,anti-GITR MoAb BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,GITR agonist BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,TNFRSF18 agonist BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS 986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS-986156
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN 323
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN323
2020-09-18T02:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-mk-4166,Code name:,MK-4166
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI 888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI-888
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,anti-globo H/MMAE ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,OBI-888/MMAE ADC OBI-999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI-999
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,anti-GPC3-scFvGC33-CAR autologous T lymphocytes
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GAP T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GPC3-CAR T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor expressed in autologous T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor-expressing autologous T cells
2020-09-18T02:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gnrh-vaccine-pep223,Code name:,PEP223
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Synonym:,humanized gpA33 x CD3 DART™ protein MGD007
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Code name:,MGD007
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Synonym:,anti-glypican 3 monoclonal antibody GC33
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Code name:,GC33
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,CAR-GPC3 T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,glypican-3-specific CAR T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,GPC3-targeted CAR autologous T cells
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,GPC3-targeted CAR autologous T cells
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,anti-GPC3 CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,glypican-3-specific CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK 102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK-102
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Synonym:,anti-GREM1 antibody monoclonal UCB6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB 6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB-6114
2020-09-18T02:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-grp78-monoclonal-antibody-pat-sm6,Code name:,PAT-SM6
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,anti-influenza A hemagglutinin epitope mAb MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,pan-influenza A mAb MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI 8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI8852
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Synonym:,anti-HB-EGF MoAb KHK2866
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Code name:,KHK2866
2020-09-18T02:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hbegf-monoclonal-antibody-u3-1565,Code name:,U3-1565
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 autologous CAR-transduced T cells
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 CAR autologous PBLs
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70-CAR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T02:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcv-e2-monoclonal-antibody-mbl-hcv1,Synonym:,MBL-HCV1
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Synonym:,Factor VIII
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Abbreviation:,FVIII
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Code name:,BAY94-9027
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,ADC A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,anti-HER2 ADC A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A 166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A-166
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,ADC ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,anti-HER2 ADC ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Code name:,ARX788
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,ADC BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,anti-HER2 ADC BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT 8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT-8001
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,ADC DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,antibody-drug conjugate DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP-303c
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Synonym:,ADC MEDI4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI-4276
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,ADC RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,anti-HER2 ADC RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48-ACD
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,anti-HER2 heterodimeric antibody KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,HER2 bispecific antibody KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN 026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN-026
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Synonym:,anti-HER2 bispecific ADC ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ADC ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW-49
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Synonym:,anti-HER2 ISAC NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH 395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH-395
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B 002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B-002
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P06
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P6
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX 22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX-22
2020-09-18T02:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791831,Code name:,PRS-343
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2/anti-CD3 bispecific monoclonal antibody 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,ARG-6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC-4017
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG6194
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody GBR 1302
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Code name:,GBR1302
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Synonym:,anti-HER2 x anti-HER3 bispecific monoclonal antibody MCLA-128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA 128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA-128
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,ADC XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,anti-HER2 ADC XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Code name:,XMT-1522
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Synonym:,HER2 x HER2 bispecific antibody ZW25
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Code name:,ZW25
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 DC vaccine
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 DC vaccine
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 dendritic cell vaccine
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-MA ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-monoamide ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Code name:,DHES0815A
2020-09-18T02:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-car-autologous-cmv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-CAR-engineered autologous PBLs
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-chimeric antigen receptor-engineered autologous peripheral blood lymphocytes
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,CART-HER-2 cells
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,HER-2 CAR-expressing autologous T-lymphocytes
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,ADC B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,anti-HER2-DM1 antibody-drug conjugate B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,recombinant humanized anti-HER2 monoclonal antibody-MCC-DM1 B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B 003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B-003
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,antibody-drug conjugate PF-0680410
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-HER2-vcAur0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-HER2 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-Her2-vc0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF 06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF-068041033
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Synonym:,ADC U3 1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3 1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402a
2020-09-18T02:39:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-gsk2849330,Code name:,GSK2849330
2020-09-18T02:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-ljm716,Code name:,LJM716
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Synonym:,anti-hepatocyte growth factor monoclonal antibody TAK-701
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Code name:,TAK-701
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,EZN-2968
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,RO7070179
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 lentiviral vector sh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LV-expressing sh5/C46 Cal-1
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,Cal-1 vector
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46 vector
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Code name:,Cal-1
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,anti-HLA-A2/NY-ESO1 TCR-transduced autologous T cells
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-HLA-A2/NY-ESO1 TCR-transduced T lymphocytes
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,anti-HLA-DR moAb L243
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,hL243gamma4P
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Code name:,IMMU-114
2020-09-18T02:40:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-chorionic-gonadotropin-vaccine,NA,NA
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Synonym:,anti-huGITR monoclonal antibody TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR mAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR MoAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Code name:,TRX518
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Synonym:,anti-human CD51 monoclonal antibody EMD 525797
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Code name:,EMD 525797
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Synonym:,anti-intercellular adhesion molecule-1 monoclonal antibody BI-505
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Code name:,BI-505
2020-09-18T02:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-antibody-gsk3359609,Code name:,GSK3359609
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-ICOS BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-inducible T-cell co-stimulator BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS 986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS-986226
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Synonym:,anti-ICOS antibody KY1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY 1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY-1044
2020-09-18T02:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-medi-570,Code name:,MEDI-570
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Synonym:,anti-insulin-like growth factor 1/2 monoclonal antibody MEDI-573
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Code name:,MEDI-573
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Synonym:,anti-CD122 monoclonal antibody AVE1642
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Code name:,AVE1642
2020-09-18T02:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-recombinant-monoclonal-antibody-biib022,Code name:,BIIB022
2020-09-18T02:40:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-ca-18c3,Code name:,CA-18C3
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Synonym:,monoclonal antibody TNX-650
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Code name:,TNX-650
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Synonym:,ATAN
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Aitan
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Rivoceranib
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Code name:,YN968D1
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Synonym:,HuMab-IL15 AMG 714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG 714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG714
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM 112
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM112
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Synonym:,dectrekumab/VAK296
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX-258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694 plus QAX576
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694/QAX576
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Synonym:,BMS-986253
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,HuMax-IL8
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX 018
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX-018
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-ILDR2 inhibitor BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-immunoglobulin-like domain containing receptor 2 MoAb BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,ILDR2 function-blocking antibody BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,immune checkpoint inhibitor BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY 1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY-1905254
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-leukocyte immunoglobulin-like receptor 2 monoclonal antibody MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-LIR2 monoclonal antibody MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK 4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK-4830
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN 1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN-1007
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Synonym:,Dentoxol mouthrinse
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Foreign brand name:,Dentoxol
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Synonym:,integrin-targeted immunoconjugate IMGN388
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Code name:,IMGN388
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Synonym:,anti-IL6 monoclonal antibody ALD518
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Code name:,ALD518
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1 alpha monoclonal antibody MABp1
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1amonoclonal antibody
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,US brand name:,Xilonix
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Code name:,MABp1
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO IONIS-IRF4-2.5Rx
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,IONIS-IRF4-2.5Rx
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION 251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION-251
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,1-7F9
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,IPH 2101
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Synonym:,anti-KIR3DL2 mAb IPH4102
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Code name:,IPH4102
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR autologous PBL
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-K-RAS G12D mTCR-transduced autologous PBLs
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,autologous PBL transduced with anti-KRAS G12D mTCR
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-K-RAS G12V mTCR-transduced autologous PBLs
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-KRAS G12V mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti LAG-3 MoAb
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti-LAG-3 monoclonal antibody
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Code name:,BI 754111
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Synonym:,anti-LAG-3 monoclonal antibody IBI110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI 110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI-110
2020-09-18T02:42:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-lag525,Code name:,LAG525
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK 4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK-4280
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Synonym:,anti-LAG-3 MoAb REGN3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN 3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN3767
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym 022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym-022
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-LAG-3 monoclonal antibody TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-lymphocyte activation gene 3 protein monoclonal antibody TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR 033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR-033
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 bispecific antibody FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 Mab2 FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,Mab2 FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Code name:,FS118
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Synonym:,anti-LAMP1 ADC SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,ADC SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,SAR428926
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,autologous-derived LeY-targeted CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted autologous CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted CAR-T cells
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Synonym:,ET-101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC-101
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC 1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC-1
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,AB0024
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,GS-6624
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Synonym:,ADC DLYE5953A
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Code name:,DLYE5953A
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC Molecule IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,T-cell redirecting bi-specific biologic IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMC C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMCC103C
2020-09-18T02:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-masp-2-monoclonal-antibody-oms721,Code name:,OMS721
2020-09-18T02:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-m-csf-monoclonal-antibody-mcs110,Code name:,MCS110
2020-09-18T02:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-antibody-drug-conjugate-bms-986148,Code name:,BMS-986148
2020-09-18T02:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-meso-CAR vector-transduced autologous T cells
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-mesothelin recombinant cytolytic fusion protein RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN cFP RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN-PE24 cFP LMB-100
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,LMB-100
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG 7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG-7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO 6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO6927005
2020-09-18T02:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-icasp9m28z-car-transduced-autologous-t-lymphocytes,Synonym:,iCasp9M28z T cells
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Synonym:,anti-mesothelin/MMAE ADC RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,ADC RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC 88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC-88
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,anti-mesothelin CIR mRNA-electroporated autologous T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-mesothelin mRNA-transfected CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous redirected RNA meso-CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,meso-CART
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Abbreviation:,CART-meso
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006/Hu9338
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006-Hu9338
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym015
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym-015
2020-09-18T02:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-egfr-monoclonal-antibody-ly3164530,Code name:,LY3164530
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502-01
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA donor T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA T cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide derived expansion against MiHAs cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide-derived expansion cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA T lympocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA-specific T cells
2020-09-18T02:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mmp-9-monoclonal-antibody-gs-5745,Code name:,GS-5745
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR T Cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR-transduced autologous T cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-mucin1 autologous CAR T cells
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16/CD3-directed bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16xCD3 bispecific T-cell engager REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN 4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN-4018
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,ADC DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,THIOMAB-drug conjugate DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,RG7882
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17 x anti-CD3 BiTE AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17/CD3 bispecific antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,BiTE antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17/CD3-directed bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17xCD3 bispecific T-cell engager AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG-199
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Synonym:,maytansinoid-conjugated anti-myeloma monoclonal antibody BT-062
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Code name:,BT-062
2020-09-18T02:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myostatin-monoclonal-antibody-ly2495655,Code name:,LY2495655
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,NaPi2b-targeted antibody-drug conjugate XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT 1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT-1592
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,anti-NaPi2b MoAb XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,MoAb XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT 1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT-1535
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Synonym:,ADC DNIB0600A
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Code name:,DNIB0600A
2020-09-18T02:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-monoclonal-antibody-drug-conjugate-ags-22m6e,Code name:,AGS-22M6E
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,US brand name:,Atengenal
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Abbreviation:,A10
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Chemical structure:,"3-phenylacetylamino-2, 6-piperidinedionebenzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-"
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,US brand name:,Astugenal
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Abbreviation:,AS2-1
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Chemical structure:,"L-glutamine, N2-(phenylacetyl)-, monosodium salt, mixture with sodium benzeneacetate"
2020-09-18T02:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-neuropilin-1-monoclonal-antibody-mnrp1685a,Code name:,MNRP1685A
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Synonym:,BSCT 10 % ointment
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Code name:,BIL-010t
2020-09-18T02:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nucleolin-aptamer-as1411,Code name:,AS1411
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,anti-NY-ESO-1 TCR transduced autologous T cells TAEST16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,NY-ESO-1 antigen specific affinity-enhanced TCR transduced autologous T cells
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST 16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST16001
2020-09-18T03:42:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-tcr-transduced-autologous-cd62l-derived-t-lymphocytes,Synonym:,autologous CD62L+-derived T lymphocytes transduced with NY-ESO-1-specific TCR
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,bispecific NY-ESO-1- and LAGE-1A-specific TCR/anti-CD3
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,HLA- A*0201-restricted NY-ESO-1- and LAGE-1A-specific soluble TCR/anti-CD3 bispecific molecule
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Code name:,IMCnyeso
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,agonistic anti-OX40 monoclonal antibody ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,anti-OX40 agonistic monoclonal antibody ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV 368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV-368
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS 986178
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS-986178
2020-09-18T03:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-pf-04518600,Code name:,PF-04518600
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Synonym:,anti-CD134 monoclonal antibody
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-CD134 MoAb
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-OX40 MoAb
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI 101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI-101
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI0562
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI-0562
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR Retroviral Vector-Transduced PBL
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR-Transduced PBL
2020-09-18T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-fusion-protein-amp-224,Code name:,AMP-224
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609 A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609-A
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN 2034
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN2034
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK 105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK-105
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG 404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG-404
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD 100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD-100
2020-09-18T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bi-754091,Code name:,BI 754091
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F 520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F-520
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX 008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX-008
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX 4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX-4014
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Synonym:,LZM009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM 009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM-009
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Synonym:,antprogrammed cell death 1 monoclonal antibody AMP-514
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,AMP-514
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,MEDI0680
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA 0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA00012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA-0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA 012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA012
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Synonym:,anti-PD1 monoclonal antibody Sym021
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Code name:,Sym021
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/anti-CTLA-4 monoclonal antibody mixture PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD1/CTLA4 antibodies PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/CTLA-4 MabPair PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,bifunctional MabPair product PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB 205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB-205
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,bispecific DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,dual-affinity retargeting protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 bispecific DART molecule MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD 019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD-019
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Synonym:,HER2/PD-1 bi-specific antibody BH 2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH 2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH-2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI 315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI-315
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Synonym:,anti-PD1/anti-LAG3 bispecific antibody RO7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO 7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO-7247669
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,bispecific DART protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,dual-affinity retargeting protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 bispecific DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Code name:,MGD013
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,anti-PD-1/PD-L1 bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,recombinant anti-PD-1/anti-PD-L1 bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI 318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI-318
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,anti-PD-1/PD-L1 bispecific antibody LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,bispecific antibody LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY 3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY3434172
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Synonym:,anti-PD1/CD47 bi-specific antibody fusion protein HX009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX 009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX-009
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD-1 x CTLA-4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD1/anti-CTLA4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK 104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK-104
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,anti-PD-1/anti-CTLA-4 XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 bispecific antibody XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb 20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb20717
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,anti-PD1/anti-ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,PD1 x ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb 23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb-23104
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1 x TIM-3 bispecific antibody RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1/anti-TIM-3 bispecific antibody RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO 7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO-7121661
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Synonym:,anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Code name:,MEDI-575
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A 167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A-167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KLA167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL-A167
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD 135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD-135
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB A333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGBA333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB-A333
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Synonym:,anti-PD-L1 monoclonal antibody TQB2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT 502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT-502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB 2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB-2450
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK 301
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK-301
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Synonym:,anti-PD-L1 monoclonal antibody WBP 3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS 1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS-1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP 3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP-3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WPB3155
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ 053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ-053
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Synonym:,PD-L1-targeting Monoclonal Antibody HLX20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX 20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX-20
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC 001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC-001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI 3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI-3031
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,anti-PD-L1 MoAb KN035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN 035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN035
2020-09-18T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-mdx-1105,Code name:,MDX-1105
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,anti-PDL1 monoclonal antibody MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,humanized anti-PD-L1 monoclonal antibody MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB 2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB-2311
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,HTI-1088
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,SHR-1316
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Synonym:,anti-PDL1 monoclonal antibody TG-1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG 1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG-1501
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,anti-PDL1 monoclonal antibody ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,STI-A1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STI A1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STIA1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB 001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB-001
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,anti-PD-L1/CD137 bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x 41BB bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x CD137 bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,ES101
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX 105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX-105
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Synonym:,duoBody PD-L1 x 4-1BB GEN1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,BNT 311
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN 1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN-1046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Synonym:,anti-PD-L1 x CTLA-4 bispecific antibody KN046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN 046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN-046
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY 3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY-3415244
2020-09-18T03:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiperspirant-cream-f511,Synonym:,F511 cream
2020-09-18T03:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pgf-monoclonal-antibody-ro5323441,Code name:,RO5323441
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Synonym:,anti-protein kinase N3 siRNA Atu027
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Code name:,Atu027
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Synonym:,anti-placental growth factor monoclonal antibody TB-403
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Code name:,TB-403
2020-09-18T03:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pr1-hla-a2-monoclonal-antibody-hu8f4,Code name:,Hu8F4
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC molecule IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMCF106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC-F106C
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3 zumab
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3-zumab
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-programmed cell death protein 1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Code name:,PIK-PD-1
2020-09-18T03:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prolactin-receptor-antibody-lfa102,Code name:,LFA102
2020-09-18T03:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-fully-human-monoclonal-antibody-ags-1c4d4,Code name:,AGS-PSCA
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201-A488
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,anti-PSMA monoclonal antibody-monomethylauristatin E conjugate
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,prostate-specific membrane antigen antibody-drug conjugate
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Abbreviation:,anti-PSMA-MMAE-ADC
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Code name:,PSMA ADC
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMA/anti-CD28 bispecific antibody REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMAxCD28 antibody REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN 5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN-5678
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW 702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW-702
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ 63898081
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ63898081
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,anti-PSMA/CD3 bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,BITE AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,half-life extended bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,HLE-BiTE AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG-160
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,BAY2010112
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,MT112
2020-09-18T03:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-monoclonal-antibody-mor209-es414,Code name:,MOR209/ES414
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADC MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADCT 401 ADCT401
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,ADCT-401
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI 3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI-3726
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,anti-poliovirus receptor-related immunoglobulin COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,PVRIG inhibitor COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM 701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM-701
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB 223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB-223
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Synonym:,anti-ROR1 antibody-drug conjugate VLS-101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS 101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS-101
2020-09-18T03:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rspo3-monoclonal-antibody-omp-131r10,Code name:,OMP-131R10
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV protein F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,RSV-specific nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX 0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX-0171
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-S15 mAb NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-Siglec-15 monoclonal antibody NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC 318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC-318
2020-09-18T03:49:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sclu-monoclonal-antibody-ab-16b5,Code name:,AB-16B5
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Synonym:,AF-enriched egg yolk powder supplement
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Foreign brand name:,Salovum
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Synonym:,moAb VX15/2503
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Code name:,VX15/2503
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR 313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR-313
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC 95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC-95251
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Synonym:,anti-SLITRK6 antibody-drugconjugate AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Abbreviation:,anti-SLITRK6 ADC AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,ASG-15ME
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Synonym:,anti-SSTR2 x anti-CD3 monoclonal antibody XmAb18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb 18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb-18087
2020-09-18T03:50:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tag-72-monoclonal-antibody-cc49-streptavidin-conjugate,Synonym:,CC49-streptavidin
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Synonym:,anti-TF moAb ALT-836
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Code name:,ALT-836
2020-09-18T03:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-nis793,Code name:,NIS793
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-TGFb SAR-439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-transforming growth factor-beta mAb SAR439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR 439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR-439459
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,IMC-TR1
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,LY3022859
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Synonym:,lymphocyte immune globulin
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,ATGAM
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,Thymoglobulin
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Abbreviation:,ATG
2020-09-18T03:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thyroglobulin-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-thyroglobulin mTCR-transduced autologous PBL
2020-09-18T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-bms-986207,Code name:,BMS-986207
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT (OMP-313M32)
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT OMP-313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP 313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP-313M32
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Synonym:,anti-TIM3 antibody BMS-986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS 986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS-986258
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB A425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGBA425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB-A425
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN 02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN-02390
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY 3321367
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY3321367
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR 1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR-1702
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Synonym:,anti-TIM3 monoclonal antibody Sym023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym 023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym-023
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Synonym:,anti-TIM3 checkpoint inhibitor TSR-022
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Code name:,TSR-022
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Synonym:,anti-TF monoclonal antibody MORAb-066
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Code name:,MORAb-066
2020-09-18T03:51:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tlr2-monoclonal-antibody-opn-305,Code name:,OPN-305
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,bi-specific agent BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,CDH17-targeting TRAILR2 agonist BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI-905711
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Synonym:,RNAi therapeutic-targeting transthyretin ALN-TTR02
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,US brand name:,Patisiran
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Code name:,ALN-TTR02
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,anti-TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,RQR8/TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,TRBC1-targeting CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO 4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO-4
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,ADC BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-TROP2 ADC BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-Trop-2 antibody-drug conjugate BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT 8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT-8003
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,ADC SKB264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB 264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB-264
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Synonym:,ADC DS-1062a
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS 1062a
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS-1062
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-a
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-α
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,ATB-KAC-alpha
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,Chinese herbal mixture antitumor B KAC-a
2020-09-18T03:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-ro5458640,Code name:,RO5458640
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,anti-VEGF MAb hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,MAb hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV 19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV-19
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,anti-VEGF/ANG2 BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,bi-specific anti-VEGF/Ang2 nanobody BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Code name:,BI 836880
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Synonym:,VEGF-C mAb VGX-100
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Code name:,VGX-100
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX 06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX-06
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB 0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB-0254
2020-09-18T03:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-car-retroviral-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-VEGFR2 gene engineered CD8+ lymphocytes
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR3 MoAb IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR-3 monoclonal antibody IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Code name:,IMC-3C5
2020-09-18T03:53:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiviral-agent-csj148,Code name:,CSJ148
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ 61610588
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ-61610588
2020-09-18T03:53:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-von-willebrand-factor-nanobody,Synonym:,anti-vWf nanobody
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphyrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Antrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutex
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Code name:,PCI-0123
2020-09-18T03:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antrodia-cinnamomea-supplement,Synonym:,OB318
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,ammonia oxidizing bacteria-containing probiotic Mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AO bacteria-containing mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AOB-based probiotic sprayt
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic solution
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic spray
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,US brand name:,AO+ Mist
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,rADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with thrombospondin motifs 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant ADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS-13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX 930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX-930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP 655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP-655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK 755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK-755
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Synonym:,Hsp27 antisense oligonucleotide OGX-427
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,ISIS 306053
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,OGX-427
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Eoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Neoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Qapzola
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Code name:,E09
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Chemical structure:,"3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol"
2020-09-18T03:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apc8015f,NA,NA
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Synonym:,APE1/Ref-1 Inhibitor APX3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Chemical structure:,"[(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid"
2020-09-18T03:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apf530,NA,NA
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM 002A
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM-002A
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,US brand name:,Eliquis
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247-01
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl controlled-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl extended release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion hydrochloride extended-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Aplenzin
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin SR
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin XL
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Zyban
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Foreign brand name:,Forfivo XL
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,aplidine
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodidemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,US brand name:,Aplidin
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,APLD
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,DDB
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Chemical structure:,"N-[1-(1,2-dioxopropyl)-L-prolyl]didemnin A"
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,1D1O Anti-lymphoma Antibody
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal antibody 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal Antibody Hu1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,US brand name:,Remitogen
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MOAB 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MoAb Hu1D10
2020-09-18T03:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apomab,NA,NA
2020-09-18T03:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-bzl101,Code name:,BZL101
2020-09-18T03:54:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-gcs-100,Code name:,GCS-100
2020-09-18T03:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-mpc-2130,Code name:,MPC-2130
2020-09-18T03:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/739744,NA,NA
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,US brand name:,Emend
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,L-754030
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,MK-0869
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,ONO-7436
2020-09-18T03:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apricoxib,Code name:,TG01
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Synonym:,mesalazine
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Apriso
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Asacol
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Lialda
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Pentasa
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Rowasa
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Abbreviation:,5-ASA
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Chemical structure:,5-amino-2-hydroxybenzoic acid5-aminosalicylic acid
2020-09-18T03:55:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin-bovine,US brand name:,Trasylol
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,ADC BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,anti-FGFR2 antibody-drug conjugate BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY 1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY1187982
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Synonym:,Sulindac Sulfone
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,US brand name:,Aptosyn
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Code name:,FGN-1
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Chemical structure:,"(Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)"
2020-09-18T03:55:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632702,US brand name:,Aquacel AG with Hydrofiber
2020-09-18T03:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-carboxymethylcellulose-dressing,US brand name:,Aquacel Dressing
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,17 beta-estradiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,Estraldine
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Aquadiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Estrace
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vagifem
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vivelle
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Dimenformon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogyn
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Code name:,SU101
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogynets
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Ovocylin
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Progynon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Abbreviation:,ESDL
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Chemical structure:,"(17beta)-estra-1,3,5(10)-triene-3,17-diol"
2020-09-18T03:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment,US brand name:,Aquaphor
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,anti-infective vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,antixerophthalmic vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophthol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophtholum
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Biosterol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Lard-Factor
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Oleovitamin A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Ophthalamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A alcohol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A USP
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A1
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Vitaminum A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Aquasol A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Del-Vi-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Pedi-Vit-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,A 313
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Arovit
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avibon
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avitol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Axerol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Biovit-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ido A 50
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Idrurto A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ledovit A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Micelle A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Mulsal A Megadosis
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Rinocusi Vitaminico
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vitaminoftalmina
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vogan
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Chemical structure:,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol"
2020-09-18T03:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-bms-641988,Code name:,BMS-641988
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Synonym:,Novel Erythropoiesis Stimulating Protein
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,US brand name:,Aranesp
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Foreign brand name:,Nespo
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Abbreviation:,NESP
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Code name:,KRN321
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,US brand name:,Arava
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Chemical structure:,"4-isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-"
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,agonist redirected checkpoint fusion protein SL-279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,PD1-Fc-OX40L ARC fusion protein
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL 279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL-279252
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,IMMU-4
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,US brand name:,CEA-Scan
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,US brand name:,Arcoxia
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,L-791456
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,MK-0663
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Chemical structure:,5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,US brand name:,Aredia
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Foreign brand name:,Aminomux
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Code name:,GCP-23339A
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Synonym:,6R-5-10-methylenetetrahydrofolate
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,US brand name:,Modufolin
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Abbreviation:,6R-MTHF
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Chemical structure:,"(6R)-5,10-methylenetetrahydrofolate[6R] 5,10-methylenetetrahydrofolate[6R]-5,10-methylene-tetrahydrofolate6R-5,10-methyleneTHF6R-methylene THFmethylenetetrahydrofolic acid, L-(+)-"
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB-1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,INCB001158
2020-09-18T03:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798381,Synonym:,ARG-1 peptide vaccine
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Synonym:,"L-arginine, butanoate (3:4)"
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Code name:,VX-105
2020-09-18T03:57:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793609,US brand name:,R-Gene 10
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Synonym:,arginine/nucleotides/omega-3 fatty acids/olive oil polyphenols/antioxidants/L-carnitine nutritional supplement
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Foreign brand name:,Bi1 Procare
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Immun-Aid
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Impact
2020-09-18T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng--gingko-biloba-damiana-based-supplement,US brand name:,ArginMax
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,US brand name:,Aricept
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Code name:,E-2020
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Chemical structure:,"1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride"
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,US brand name:,Aristocort
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,Chemical structure:,"(11beta,16alpha)-9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione"
2020-09-18T03:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium,US brand name:,Arixtra
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,US brand name:,Nuvigil
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,Chemical structure:,(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
2020-09-18T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arnebia-indigo-jade-pearl-topical-cream,Acronym:,AIJP
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,US brand name:,Aromasin
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Abbreviation:,PNU 155971
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Code name:,FCE-24304
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Chemical structure:,"6-Methyleneandrosta-1,4-diene-3,17-dione"
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,liposomal neodecanoic acid platinum complex
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,US brand name:,Aroplatin
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Abbreviation:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Chemical structure:,"liposome-entrapped cis-bis-neodecanoate-trans-R,R-1,2-diaminocyclohexane platinum (II)"
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,US brand name:,Arranon
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,GW506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Chemical structure:,2-amino-6-methoxypurine arabinoside2-amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic (III) Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic Sesquioxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid Anhydride
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,White Arsenic
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,US brand name:,Trisenox
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Abbreviation:,AS2O3
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,arsenic trioxide formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,As2O3 formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,oral arsenic trioxide formulation
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH-2014
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Synonym:,sublingual artemether spray
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Code name:,LON002
2020-09-18T03:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artesunate,Abbreviation:,ART
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke extract
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke W.P.C.
2020-09-18T03:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artificial-saliva-spray,Foreign brand name:,Hypozalix spray
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR antagonist BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR inhibitor BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,aryl hydrocarbon receptor inhibitor BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY 2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY-2416964
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,US brand name:,Arzerra
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Foreign brand name:,HuMax-CD20
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,2F2
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,GSK1841157
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,LY353381 Hydrochloride
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,SERM-3
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Code name:,LY353381.HCl
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Chemical structure:,2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]benzo[b]thiophene-6-ol hydrochloride
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Arepanrix
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Pandemrix
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Synonym:,mesalazine
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Apriso
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Asacol
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Lialda
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Pentasa
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Rowasa
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Abbreviation:,5-ASA
2020-09-18T03:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Chemical structure:,5-amino-2-hydroxybenzoic acid5-aminosalicylic acid
2020-09-18T03:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asaley,Synonym:,Asalex
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Synonym:,allosteric Bcr-Abl tyrosine kinase inhibitor ABL001
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Code name:,ABL001
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,aethoxysklerol
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,dodecylnonaoxyethylene glycol monoether
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,Laureth-9
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,US brand name:,Asclera
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T03:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ashwagandha-root-powder-extract,NA,NA
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,ginseng root
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Korean ginseng
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Panax ginseng
2020-09-18T03:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ask1-inhibitor-gs-4997,Code name:,GS-4997
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,US brand name:,ASONEP
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,Code name:,LT1009
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T03:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T03:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp4132,NA,NA
2020-09-18T03:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp9853,NA,NA
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,ASP-1
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,asparaginase II
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,Colaspase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparaginase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparagine amidohydrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,Elspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,L-Asnase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Kidrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Laspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leucogen
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leunase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Paronal
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Spectrila
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,Lcf-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,MK-965
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,Re-82-TAD-15
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,asparaginase-Erwinia
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,crisantaspasum
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,cristantaspase
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,eATG
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,Erwinia L-asparginase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspaasi
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspas
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,US brand name:,Erwinaze
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Foreign brand name:,Erwinase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,calaspargase pegol
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,SC-PEG E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,succinimidyl carbonate monomethoxypolyethylene glycol E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,US brand name:,Asparlas
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Code name:,EZN-2285
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,[211At]OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,211At-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine 211-labeled anti-CD38 monoclonal antibody OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine At 211 anti-CD38 MoAb OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine-211-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,At211-OKT10-B10
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Synonym:,Astaxanthine
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Foreign brand name:,Algalif
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Chemical structure:,"(3S,3'S)-3,3'-dihydroxy-beta,beta-carotene-4,4'-dione"
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Synonym:,Am/Ag/Tk herbal extract SH003
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Code name:,SH003
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,Astragalus membranaceus/Panax ginseng/Atractylodes chinensis Koidz/ Cimicifuga foetida/A. macrocephala Koidz/Alisma orientale Juzep/Citrus reticulata Blanco herbal supplement
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,QING SHU YI Qi Tang
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Abbreviation:,QSYQT
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Synonym:,recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Abbreviation:,recombinant MAGE-A3 ASCI GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Code name:,GSK1203486A
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Synonym:,amsalog
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Code name:,CI-921
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Chemical structure:,"4-acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino-N,5-dimethyl"
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Abbreviation:,ASV
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Code name:,BMS-650032
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Atacand
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Biopress
2020-09-18T04:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atamestane,NA,NA
2020-09-18T04:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atenolol,NA,NA
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Synonym:,anti-PD-L1 monoclonal antibody MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,US brand name:,Tecentriq
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RG7446
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RO5541267
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Synonym:,lymphocyte immune globulin
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,ATGAM
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,Thymoglobulin
2020-09-18T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Abbreviation:,ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,antithymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,anti-thymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,ATG equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,equine ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,horse ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,"lymphocyte immune globulin, anti-thymocyte globulin equine"
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,US brand name:,Atgam
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,hATG
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Synonym:,azaspirane
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Code name:,SK&F106615
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Chemical structure:,"N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine"
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,US brand name:,Ativan
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,Chemical structure:,"7-chloro-5-(2-chlorophenyl)-1, 3-dihydro-3-Hydroxy-1,4- benzodiazepin-2-one"
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Synonym:,ataxia telangiectasia mutated kinase inhibitor M 3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M 3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M3541
2020-09-18T04:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-kinase-inhibitor-azd0156,Code name:,AZD0156
2020-09-18T04:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atn-161,NA,NA
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,US brand name:,Strattera
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,Chemical structure:,(-)-N -methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride(-)-N-methyl-gamma(2-methylphenoxy)benzenepropamine Hydrochloride
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Synonym:,atorvastatin calcium trihydrate
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,US brand name:,Lipitor
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Code name:,CI-981
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Synonym:,ATR inhibitor BAY1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY 1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY-1895344
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M 1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M-1774
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M 6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,VX-970
2020-09-18T04:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-101,NA,NA
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,All-trans-retinoic acid liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposome
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoinLF
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,US brand name:,Atragen
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Abbreviation:,L-ATRA
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Code name:,AR-623
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,US brand name:,Xinlay
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,(+)-A 127722
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT 627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT-627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Chemical structure:,"(2R,3R,4S)-4-(1,3-benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid monohydrochloride"
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,US brand name:,Atromid-S
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Abbreviation:,CFB
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Chemical structure:,2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl esterethyl 2-(4-chlorophenoxy)-2-methylpropanoateethyl p-chlorophenoxyisobyturate
2020-09-18T04:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atropine-sulfate,NA,NA
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx.5T4 vaccine
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx1.5T4 vaccine
2020-09-18T04:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-listeria-monocytogenes-crs-100,NA,NA
2020-09-18T04:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/auranofin,US brand name:,Ridaura
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound recombinant human tumor necrosis factor
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound rhTNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound TNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,US brand name:,Aurimmune
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Code name:,CYT-6091
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Synonym:,aurixim antibody conjugate
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,US brand name:,Aurixim
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Code name:,CON-4619
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,Synonym:,sodium aurothiomalate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Aurolate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Myochrysine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,AK 01 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,aurora kinase A inhibitor LY3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY 3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY-3295668 erbumine
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Synonym:,TAS-2104
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Code name:,TAS-119
2020-09-18T04:03:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-tyrosine-kinase-inhibitor-enmd-2076,Code name:,ENMD-2076
2020-09-18T04:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-kinase-inhibitor-tak-901,Code name:,TAK-901
2020-09-18T04:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-c-kinase-inhibitor-gsk1070916a,Code name:,GSK1070916A
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,AK A/B inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,multi-kinase inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,TT 00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT-00420
2020-09-18T04:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-amg-900,NA,NA
2020-09-18T04:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-bi-811283,Code name:,BI 811283
2020-09-18T04:03:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-mln8054,Code name:,MLN8054
2020-09-18T04:04:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-pf-03814735,Code name:,PF-03814735
2020-09-18T04:04:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-sns-314,Code name:,SNS-314
2020-09-18T04:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-ttp607,Code name:,TTP607
2020-09-18T04:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-vegfr2-inhibitor-cyc116,Code name:,CYC116
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 cells
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 T cells
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Code name:,ACTR707
2020-09-18T04:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ad-cd154-transduced-cll-b-cells,Synonym:,autologous Ad-ISF35-transduced CLL B cells
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Synonym:,autologous AFP-specific TCR-transduced T cells C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR 055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR-055
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous AML/DC fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous DC/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous dendritic cell/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,DC/AML fusion cell vaccine
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,autologous BCMA-specific CAR T-cells IM21
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,IM21 CAR-T cells
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-T cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-transduced T Cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous T Cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE 585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE-585
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Synonym:,autologous CD8+ T cells expressing anti-BCMA CAR Descartes-11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes 11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-011
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-11
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous anti-BCMA CAR-T cells JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA 41BBz CAR-T cells JCARH-125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR-T cells JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH-125
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Synonym:,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing memory T cells bb21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,BB 21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb-21217
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,anti-BCMA-CAR-41BB-CD3zeta-expressing T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,BCMA Car-T (CT053)
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CAR-BCMA T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T cells
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT 053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT-053
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,autologous anti-BCMA-CAR CD4+/CD8+ cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA CAR-CD4+/CD8+ T cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA-specific CAR-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Code name:,FCARH143
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous anti-BCMA centyrin-based chimeric antigen receptor-expressing Tscm
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CAR-T cells
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CARTyrin-T cells
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Code name:,P-BCMA-101
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,anti-BCMA-CAR-mRNA-transfected autologous CD8+ T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8-positive T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Code name:,Descartes-08
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA 4-1BBz CAR T cells CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA-specific CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,CART-BCMA cells
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Abbreviation:,CART-BCMA
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,autologous RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA Anti-CD123 CAR T Cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,snti-CD123 CAR mRNA-electroporated autologous T lymphocytes
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Synonym:,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T cells BinD19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD 19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 CAR-T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 Humanized scFv TCRz-41BB-CAR lentiviral vector-transduced autologous T lymphocytes
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 T lymphocytes
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD3zeta-4-1BB-expressing CART-19 cells
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous CD19-specific CAR-T cells PZ01
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous PZ01 CAR-T cells
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Code name:,PZ01
2020-09-18T04:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes,Synonym:,autologous anti-CD19-CAR T cells
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Synonym:,autologous CLIC-1901 CAR-T cells
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC 1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC-1901
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Synonym:,autologous CD19-specific CAR-T cells IM19
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Code name:,IM19
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,anti-CD19-CAR T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,autologous anti-CD19 chimeric antigen receptor T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CAR19 T lymphocytes TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CD19-CAR-T TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Code name:,TBI-1501
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,AUTO1 CAR-T Cells
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 Chimeric Antigen Receptor T-lymphocytes AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous CD19-targeted CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAT-41BBZ CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO 1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO-1
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CART cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CAR-T cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous CD19-specific CAR-T cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Code name:,C-CAR011
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CART cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CAR-T cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous CD19-specific CAR-T cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Code name:,SJCAR19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,CD19-targeted T cell antigen coupler TAC01-CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,TAC01-CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01 CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01CD19
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM)
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM) T Cells
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET 190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190L1
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous anti-CD19/20 bispecific CAR-CD28-BBz-EGFRt+-expressing Tn/mem cells
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous Anti-CD19/20 CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing naive and memory T lymphocytes
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/20 bispecific CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/CD20 bispecific nanobody-derived CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous CD19/CD20 bispecific CAR T cells
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Synonym:,anti-CD19/CD22 CAR autologous T lymphocytes AUTO3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO 3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO-3
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ CM T lymphocytes JCAR014
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Code name:,JCAR014
2020-09-18T04:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-4-1bb-cd3zeta-egfrt-expressing-t-lymphocytes,NA,NA
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,autologous CD19CAR-CD28tm/4-1BBzeta-T2A-EGFRt CART cells
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,SCRI-huCAR19v1
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous TriCAR-T-CD19 cells
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous trifunctional anti-CD19 CAR T cells
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,autologous CD19/CD22CAR-HER2t-EGFRt-expressing T lymphocytes
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,bispecific anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,anti-CD20 CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,autologous CD20-targeted CAR-transduced CD4/CD8-enriched T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,CD20-targeting CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,MB-CART20.1
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 CAR T cells CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 scFv CAR 4-1BB-TCRz-expressing T lymphocytes CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s-expressing T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Code name:,CART22-65s
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous anti-CD38 A2 CAR2 T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 CAR T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 T lymphocytes
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CD38-A2 CAR2-expressing T lymphocytes
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,autologous CRISPR-edited CD7-targeting CAR-CD28zeta T cells
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,CD7.CAR/28zeta CAR CRISPR-edited T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous anti-Claudin18.2 CAR-T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18.2 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,Claudin18.2-redirected autologous T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Code name:,CT041
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,autologous anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1 CAR-T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1-CAR T lymphocytes
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous anti-EGFR CAR-transduced CXCR 5-modified T cells
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous CXCR5-modified anti-EGFR CAR-T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,anti-PD-1/PD-L1-antibodies-expressing
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous anti-PD-1/anti-PD-L1 antibodies-expressing anti-EGFRvIII CAR T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous EGFRvIII-4SCAR-IgT
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous GBM-specific CAR-T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,EGFRvIII-4SCAR-IgT cells-producing PD1 and PD-L1 antibodies
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,PD-1/PD-L1 antibody-producing T cells (IgT)
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous anti-FLT3 CAR T lymphocytes AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous FLT3 CAR-T cells AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG-553
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing NKTs
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,G28z.15 NKTs
2020-09-18T04:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560190,NA,NA
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR lentiviral vector-transduced autologous T cells
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR-T cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous HER2(EQ)BBζ/CD19t+ Tcm cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous memory enriched HER2(EQ)BBzeta/CD19t+-expressing T cells
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Synonym:,ET140202 autologous T cells
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET 140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET-140202
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-transduced T cells ET1402L1
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous ET1402L1-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous T cells transduced with ET1402L1-CAR
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,ET1402L1-CAR-T cells
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T lymphocytes AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,CAR-T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC 100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC-100
2020-09-18T04:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560192,NA,NA
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T lymphocytes
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,Hu-CART-meso cells
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,mesothelin-specific CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7 CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7-CAR T-lymphocytes
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,MG7-targeted chimeric antigen receptor T cells
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,anti-MUC1*-CAR-4-1BB-CD3zeta-expressing autologous T lymphocytes
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous HuMNC2-CAR44
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 CAR T cells
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 T lymphocytes
2020-09-18T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793184,Synonym:,autologous Muc1/CD33/CD38/CD56/CD123-specific gene-engineered CAR-T cells
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,anti-NY-ESO-1 mTCR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,autologous anti-NY-ESO-1 Murine TCR retroviral vector-transduced peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,NY-ESO-1-specific mTCR retroviral vector-transduced autologous PBLs
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,autologous NY-ESOc259T GSK3377794
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,genetically engineered NY-ESO-1/LAGE-1 specific (c259) T cells GSK3377794
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,anti-PD1 antibody-activated autologous TILs
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,autologous anti-PD-1 antibody-activated TILs
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA(dCH2)BBz-CAR T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,PSCA(dCH2)BBzeta-CAR T cells
2020-09-18T04:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-cells,Synonym:,autologous anti-prostate-specific membrane antigen gene-modified T-cells
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-CS1 CAR-expressing T cells
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-SLAMF7 CAR-expressing T lymphocytes
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,autologous anti-SLAMF7 CAR T cells
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous anti-AXL CAR-T Cells CCT30138
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous CAR-T cells targeting AXL CCT301-38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,CCT30138 CAR-T cells
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301 38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301-38
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Synonym:,HER2/neu-specific autologous B-cell/monocyte vaccine BVAC-B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVACB
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC-B
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells (AUTO2) targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous APRIL CAR T cells
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous CAR T product AUTO2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO 2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,SUB-96123
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA CAR4-1BBz T cells
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA:TCRz-4-1-BB CAR-T cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,autologous LCAR-B4822M CAR T cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,BCMA-specific CAR-expressing T lymphocytes LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M CAR T lymphocytes
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M-02 cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCARB4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LLCAR B4822M
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Synonym:,autologous BCMA-targeted NEX-T CAR-T Cells CC-98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC 98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC-98633
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,autologous CD34+ HSCs transduced with LentiGlobin BB305
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305 lentiviral vector-transduced autologous CD34+ HSCs
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,lentiviral b-A(T87Q)-globin-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,US brand name:,LentiGlobin BB305 Drug Product
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous anti-BCMA CAR-T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous bi-epitope CAR T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,LCAR-B38M-transduced CAR-T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,LCAR-B38M
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,bispecific CAR T cells GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,dual CAR-T cells GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC 022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC-022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022F
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,betaglucin soluble gel
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,epiglucan gel
2020-09-18T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bone-marrow-derived-cd34-cxcr4-positive-stem-cells-amr-001,Code name:,AMR-001
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Synonym:,autologous CAR T cells PRGN-3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN 3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN-3006
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30.CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30-CD28zeta-CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLs co-expressing CD30-CARCD28zeta and CCR4
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,CCR4-CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,SFG.CCR4-CAR.CD30 autologous T lymphocytess
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4SCAR123 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4S-CD123-CAR-T cell
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123 CAR-T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-4SCAR-expressing T lymphocytes
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Code name:,4SCAR123
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,anti-CD123-CAR/CD28-costimulatory retroviral vector-transduced autologous T lymphocytes
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,CD123R(EQ)28zeta/EGFRt+ T cells
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,anti CD123-CAR/CD28-CD3zeta-EGFRt-expressing autologous T lymphocytes MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,autologous CD123CAR-CD28-CD3zeta/EGFRt+ T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123CAR-CD28-CD3zeta-EGFRt lentiviral-transduced autologous T lymphocytes MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123-CD28-CD3zeta.EGFRt+ autologous T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB 102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB-102
2020-09-18T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642488,Synonym:,autologous CD133-positive brain tumor stem cell mRNA-pulsed autologous dendritic cell vaccine
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous CD138-specific CAR T lymphocytes
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-sepcific CAR T cells
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CD171 CAR+ T cells
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CE7R CAR T cells
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Synonym:,autologous CD19 CAR-transduced CD4/CD8 enriched T cells MB-CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MBCART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB-CART19.1
2020-09-18T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd22-chimeric-antigen-receptor-t-cells,Synonym:,autologous CD19/CD22 CAR T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,autologous Anti-CD19/PD-1 bispecific CAR-T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,CD19/PD-1 bispecific CAR T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,MC-19PD1 CAR-T cells
2020-09-18T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-28z-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,CAR 19-28z T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4SCAR19 cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4S-CAR-T19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous anti-CD19 CAR-T cells 4SCAR19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19- scFv/CD28/CD137/CD27/CD3z-iCasp9 4SCAR-19 T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19-scFv/CD28/CD137/CD27/CD3z-iCasp9 CAR-T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Code name:,4SCAR19
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DC vaccine
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19-CAR-specific/truncated EGFR lentiviral vector-transduced autologous T cells
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19R:CD28:lentiviral/EGFRt+ T cells
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-EGFRt T cells
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,CD19-CD8CD28zCAR-specific-mbIL15-HER1t T lymphocytes
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Synonym:,autologous anti-CD19 CAR T cells JWCAR029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR 029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR-029
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous anti-CD19-CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,CD19 FasT CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasT CAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasTCAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,GC007F CAR-T cells
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC 007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC-007F
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4SCAR20 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4S-CD20-CAR-T cell
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20 CAR-T cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20-CD28-CD137-CD27-CD3z-iCasp9 CAR T-cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-4SCAR-expressing T lymphocytes
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Code name:,4SCAR20
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4SCAR22 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4S-CD22-CAR-T cell
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22 CAR-T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-4SCAR-expressing T lymphocytes
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Code name:,4SCAR22
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30 cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30-CD28zeta cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATL-expressing CD30-CAR-CD28zeta
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,autologous CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,SFG.CAR.CD30 autologous T lymphocytes
2020-09-18T04:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801353,US brand name:,Temferon
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous BCL11A-edited CD34+ hematopoietic stem/progenitor cells
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34+ hematopoietic stem cells BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34-positive BCL11A-disrupted HPCs BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,HSPCs BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Code name:,BIVV003
2020-09-18T04:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-hematopoietic-progenitor-cells,Synonym:,autologous CD34-positive HPCs
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34+ PBSCs
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34-positive PBSCs
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4SCAR38 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4S-CD38-CAR-T cell
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38 CAR-T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-4SCAR-expressing T lymphocytes
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Code name:,4SCAR38
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-antigen presenting cells
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-APC
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing CD19t
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing truncated CD19
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt and CD19-specific CAR/HER2tG
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous EGFR806/CD19-specific CAR T cells
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5.CAR/28zeta CAR T cells
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5-specific CAR-28 zeta CAR T lymphocytes
2020-09-18T04:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-melanoma-specific-t-cells,Synonym:,autologous melanoma-specific cytotoxic T lymphocytes
2020-09-18T04:13:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/693322,Synonym:,autologous CD8+ PBL sensitized To Drosophila cell-presented melanoma peptides
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific AAV-DC-CTLs
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific CTLs
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIE cells
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIEs
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated T lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated TIL
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated tumor-infiltrating lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CRISPR/Cas 9-CISH knockout TILs
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous anti-CLL1/anti-CD33 CARs-expressing T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T cells
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,CLL1-CD33 cCAR T cells
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Synonym:,autologous cNeT ATL001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL 001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL-001
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous anti-c-Met/PD-L1 CAR T cells
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous c-Met/PD-L1-specific CAR T lymphocytes
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV pp65-LAMP mRNA-loaded DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV-pp65-flLamp DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DCs
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous pp65-shLAMP-1 DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DCs
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,pp65-shLAMP-1 mRNA DCs
2020-09-18T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colon-cancer-cell-vaccine,Synonym:,OncoVAX
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,APDC vaccine
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous colorectal tumor antigen-pulsed DC vaccine
2020-09-18T04:14:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755477,Code name:,CT7/MAGE-A3/WT1 mRNA-electroporated LCs
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,anti-CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted autologous CD8+/CD34t+ T cells
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T lymphocytes
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-reactive cultured CTLs
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-specific CTL
2020-09-18T04:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytokine-induced-killer-cells,Foreign brand name:,Immuncell-LC
2020-09-18T04:14:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797088,Synonym:,autologous CAR19 T cells carrying cytoplasmic activated PD-1
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,6B11 anti-idiotype minibody-pulsed DCs induced autologous CTLs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11mini-ovarian-cytokine-induced-killer cells
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11-OCIK
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs induced with 6B11 anti-idiotype minibody-pulsed DCs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous cytotoxic T cells induced by autologous dendritic cells loaded with 6B11 anti-idiotype minibody
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-DC-CTL
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-gene-DC-CTL
2020-09-18T04:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777275,Synonym:,MUC1-peptide-DC-CTL
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Synonym:,IL-15 loaded autologous T lymphocytes TRQ15-01
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Code name:,TRQ15-01
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Synonym:,autologous DC vaccine ACT2001
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Code name:,ACT2001
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,Ad-CCL21-DC
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,DC-AdCCL21
2020-09-18T04:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-p53-vaccine,NA,NA
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Synonym:,Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,US brand name:,Uvidem
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Code name:,IDD-3
2020-09-18T04:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-autologous-tumor-mrna-human-cd40l-vaccine,Synonym:,Autologous Dendritic Cell and Tumor mRNA Human CD40L Vaccine
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,autologous DC-based immunotherapeutic AV0113
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 DC-CIT
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 dendritic cell cancer immune therapy
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Code name:,AV0113
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed DC vaccine
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed dendritic cell vaccine
2020-09-18T04:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-tumor-fusion-vaccine,NA,NA
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,Synonym:,autologous DNP-modified ovarian cancer vaccine
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,US brand name:,OVax
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous anti-HPV-16 E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous HPV-16 E6 TCR T cells
2020-09-18T04:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-ctl-cd19car-zeta,NA,NA
2020-09-18T04:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine,NA,NA
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-CTLA-4/PD-1-expressing EGFR-CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-PD-1/CTLA4-targeting antibodies-expressing EGFR-specific CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing EGFR-CAR-T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,autologous EGFRt/BCMA-41BBz CAR T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,B-cell maturation antigen-targeted EGFRt/BCMA-41BBz CAR-modified T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,EGFRt/BCMA-41BBz CAR T cell
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,EBV-specific cytotoxic T lymphocytes
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,Epstein-Barr virus-specific cytotoxic T lymphocytes
2020-09-18T04:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine,Synonym:,autologous EBV-transformed B-lymphoblastoid cell vaccine
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,US brand name:,Stromagen
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,Code name:,OTI-010
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous 4S-FRa-CAR-T cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous anti-FRa-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,chimeric antigen receptor T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,FRa-specific 4th generation CART cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Abbreviation:,4SCAR-FRa
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Synonym:,human gamma-globinG16D/short-hairpin RNA734-transduced CD34-positive cells CSL200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL 200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL-200
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,gamma-retroviral MSGV1 139 scFv EGFRvIII CAR gene-modified autologous T lymphocytes
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGv1-EGFRvIII-CAR autologous T cells
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGV1-EGFRvIII-specific CAR-transduced autologous T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified MAGE-A4 C1032 T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified melanoma antigen A4 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous MAGE-A4 C1032 TCR-modified T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous TCR-transduced MAGE-A4 C1032 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 SPEAR T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 TCR
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Code name:,ADP-A2M4
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,ADP-A2M4CD8
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified MAGE-A4 C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified melanoma antigen A4 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous MAGE-A4 C1032 TCR-modified CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous TCR-transduced MAGE-A4 C1032 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4 SPEAR CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,SPEAR T-cell ADP-A2M4CD8
2020-09-18T04:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-glioma-cell-lysate,NA,NA
2020-09-18T04:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-breast-cancer-vaccine,NA,NA
2020-09-18T04:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754007,Synonym:,GVAX colorectal cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,autologous GVAX lung cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,GVAX autologous lung cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123V
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8+ T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8-positive T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous specific HCC antigens CD8+ T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV antigen-specific TCR-redirected T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV/TCR-T cells
2020-09-18T04:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-heat-shock-protein-70-peptide-vaccine-ag-858,Code name:,AG-858
2020-09-18T04:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/643475,Synonym:,autologous TGF beta-resistant HER2/EBV-CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-AdVST
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified adenovirus-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified Ad-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified autologous AdVSTs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Abbreviation:,HER2.CAR AdVST
2020-09-18T04:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795343,Synonym:,autologous HER2 CAR/EGFRt-expressing CD4+ and CD8+ T cells
2020-09-18T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hnscc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,NA,NA
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7 T-cell receptor engineered T cells KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7-specific HLA-A*02:01-restricted TCR gene engineered autologous T lymphocytes KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE 439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE-439
2020-09-18T04:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-16-18-e6-e7-specific-tgf-beta-resistant-t-lymphocytes,Synonym:,HPVST cells
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Synonym:,autologous HPV-specific immune lymphocytes
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Abbreviation:,autologous HPV-CTLs
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically-engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Code name:,huJCAR014
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T cells
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,iC9.GD2.CAR.IL-15 T-cells
2020-09-18T04:18:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2-car-expressing-vzv-specific-t-lymphocytes,Synonym:,autologous iC9-GD2-CAR-VZV-CTLs
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,ATL-iC9-CAR-CD19
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CAR19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CARCD19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Abbreviation:,autologous iC9-CARCD19 T cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous iC9.2A.deltaNGFR.2A.CAR.CD19 T cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous inducible caspase 9-CD19-expressing autologous T lymphocytes
2020-09-18T04:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-il-21-modulated-cd8-mart1-specific-t-cells,NA,NA
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,autologous immunoglobulin idiotype-keyhole limpet hemocyanin conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,GTOP-99
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,Id-KLH conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,recombinant Id-KLH
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Abbreviation:,Id-KLH
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Synonym:,autologous IKDC-like cells
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,OC-IgT cells
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Abbreviation:,autologous IKDC
2020-09-18T04:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Synonym:,autologous EBV-specific TCR T cells YT-E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YTE001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT-E001
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Synonym:,autologous activated cytotoxic T lymphocytes/natural killer cells
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Foreign brand name:,ALECSAT
2020-09-18T04:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-cell-lysate-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642645,NA,NA
2020-09-18T04:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642644,NA,NA
2020-09-18T04:19:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-immunoglobulin-derived-scfv-chemokine-dna-vaccine,NA,NA
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous genetically-modified T cells MAGEA10c796
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE A10c796 T cells
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE-A10-specific HLA-A2-restricted TCR c796 gene-engineered lymphocytes
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Abbreviation:,MAGEA10c796 T
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,autologous anti-MAGE-A3/A6 TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 TCR engineered T lymphocytes
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGEA3/A6-targeted TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,TCR-transduced autologous T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE 718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE-718
2020-09-18T04:20:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/762213,Synonym:,anti-MAGE-A3 HLA-A*01-restricted TCR-gene engineered lymphocytes
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,FH-MCVA2TCR autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Code name:,FH-MCVA2TCR
2020-09-18T04:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798639,NA,NA
2020-09-18T04:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798704,Synonym:,autologous -peptide-pulsed mDC3/8 KRAS vaccine
2020-09-18T04:20:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-klh-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/753553,NA,NA
2020-09-18T04:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-pulsed-autologous-dendritic-cell-vaccine,Synonym:,TLPLDC vaccine
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,Agenmestencel-T
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,autologous MSC_apceth_101
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,autologous CART-meso
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,Hu-CART meso cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing meso-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing mesothelin-targeted CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing mesothelin-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA4/PD-1-targeting antibodies-expressing mesothelin-CAR-T cells
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Synonym:,anti-mesothelin mRNA-transfected autologous PBMCs MCY-M11
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Code name:,MCY-M11
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,autologous monocyte-derived lysate pulsed DCs PV-001-DC
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,PV-001-dendritic cell
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Code name:,PV-001-DC
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous cMET redirected CAR-T cells
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous mRNA CART-cMET
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,cMET CAR-mRNA-electroporated autologous T lymphocytes
2020-09-18T04:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-muc1-mannan-fusion-protein-pulsed-dendritic-cell-vaccine,Foreign brand name:,CVac
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous aDC1-induced CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous CTLs sensitized ex-vivo with autologous TAA-loaded alphaDC1
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous natural killer-like cytotoxic lymphocytes
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous NK-like CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in vitro DC-sensitized CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in-vitro DC-sensitized autologous CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,therapeutic nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,tumor neo-antigen-specific nCTLs
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin-4/anti-FAP CAR-T cells
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin4/FAP CAR-T cells
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,autologous neuroblastoma lysate/KLH-pulsed DC vaccine
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,keyhole limpet hemocyanin-pulsed dendritic cell vaccine
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKR-2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKG2D CAR-CD3zeta-DAP10-expressing T cells CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR 2 T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR-2 CAR-T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM-CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-101
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR 2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR-2
2020-09-18T04:21:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,Synonym:,autologous non-small cell lung cancer DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine
2020-09-18T04:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-peptide-specific-dendritic-cell-vaccine,Synonym:,autologous NSCLC peptide-specific DC vaccine
2020-09-18T04:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792517,Synonym:,NY-ESO-1 T Cell receptor genetically modified autologous T cells
2020-09-18T04:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-cells,NA,NA
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 TCR-expressing CRISPR-edited (TCR and PD-1) T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 transgenic TCR-expressing endogenous TCR-PD-1 gene-edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1 TCR-PD-1-CRISPR-gene-edited autologous T lymphocytes
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR-edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR-TCRendo/PD1-edited T cells
2020-09-18T04:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795738,NA,NA
2020-09-18T04:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ofa-ilrp-rna-transfected-dendritic-cell-vaccine,Synonym:,oncofetal antigen-immature laminin receptor protein-loaded autologous dendritic cell vaccine
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,autologous human OC-IgT cells
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous OC-CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous ovarian cancer-specific CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Abbreviation:,OC-CTLs
2020-09-18T04:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-tumor-cell-lysate-pulsed-dendritic-cell-vaccine,Synonym:,autologous OC-DC vaccine
2020-09-18T04:22:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-oxidized-ovarian-tumor-cell-lysate-vaccine,Synonym:,autologous OC-L vaccine
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate- and mRNA-loaded DC vaccine
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded DCs
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded dendritic cells
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous PBLs expressing mutated neoantigen-specific T-cell receptors
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous peripheral blood lymphocytes retrovirally-transduced with TCRs targeting neoantigens
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,individual patient TCR-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-reactive TCRs-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-specific TCRs gene-transduced autologous PBLs
2020-09-18T04:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792459,Synonym:,autologous PD-1 antibody expressing mesothelin specific CAR-T cells
2020-09-18T04:22:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793152,Synonym:,autologous iPD1 CD19 eCAR T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous chimeric switch receptor PD-1:CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous PD-1-targeted CSR T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,chimeric switch receptor PD1CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,PD1CD28 CSR T cells
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,autologous CAR-T Cells Targeting PD-L1 and CD80/CD86
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield CTLs
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield cytotoxic T lymphocytes
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Abbreviation:,Z-CTLs
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous lymphocytes cotransduced with genes encoding IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous PBL cotransduced with retroviral vectors encoding inducible IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12 plus anti-ESO-1 TCR PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs from ibrutinib-treated CLL patients
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs IOV-2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV 2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV-2001
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Synonym:,ALD-451 bright cells
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Code name:,ALD-451
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous anti-PRAME-TCR-expressing T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous PRAME TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,PRAME-TCR gene-modified autologous T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG 1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG-1011
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BP-GMAX-CD1
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BPX-101
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific CAR T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific chimeric antigen receptor engineered T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,GoCART BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Code name:,BPX-601
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous 4S-PSMA-CAR-T cells
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous anti-PSMA-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,chimeric antigen receptor T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,PSMA-specific 4th generation CART cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFbRDN T cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFβRDN cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,PSMA-specific/TGFb-resistant CAR-modified autologous T cells
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA 201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA-201
2020-09-18T04:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-dendritic-cell-vaccine,Abbreviation:,autologous RCC tumor lysate-DC vaccine
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous anti-ROR2 CAR-T cells CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CAR-T cells targeting ROR2 CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CCT301-59 CAR-T cells
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301 59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301-59
2020-09-18T04:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-cell-lysate,NA,NA
2020-09-18T04:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-lysate-pulsed-dendritic-cell-vaccine,NA,NA
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,"autologous T lymphocytes expressing NY-ESO-1-specific, enhanced TCRs"
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1/C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESOc259T
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous dendritic cells loaded with autologous tumor associated antigens
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous TAAs-loaded autologous DCs AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,neoantigen-loaded autologous dendritic cells AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV GBM 1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV-GBM-1
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous PBMCs TBX-3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous TBX-4000-treated human PBMCs
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,TBX-3400 cells
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX 3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX-3400
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,ACTengine IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,autologous T-cell receptor-engineered T cells IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 autologous T lymphocytes
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 T cells
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA 201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA-201
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,ACTengine IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T cells
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T-cell product
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA 202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA-202
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,ACTengine IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T cells
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T-cell product
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA 2013
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA-203
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous tetravalent DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,tetravalent autologous dendritic cell vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Code name:,MIDRIX4-LUNG
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,anti-TnMUC1-CAR-expressing autologous T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous anti-TnMUC1-CAR-expressing T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous CART-TnMUC1 cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous Tn-MUC1-specific CAR T cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous TnMUC1-targeted genetically-modified CAR T cells
2020-09-18T04:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-proteoliposome-chronic-lymphocytic-leukemia-vaccine,US brand name:,Oncoquest-L vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,AC vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,Autologous Cell Vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Abbreviation:,ATCV
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Synonym:,autologous TIL LN-144
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,US brand name:,Contego
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Code name:,LN-144
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous TILs LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous tumor-infiltrating lymphocytes LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN-145
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS 3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS-3002
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,autologous tumor antigen-associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived multi-antigen associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived WT1/PRAME/survivin-specific T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAA-T
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAATs
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous tumor-associated peptide antigen-pulsed DC vaccine KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,TAPA loaded DC vaccine
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Abbreviation:,autologous TAPA-pulsed DC vaccine KiroVAX
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous TILs
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous tumor-infiltrating lymphocytes
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Code name:,MDA-TILs
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC vaccine
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DCs
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-loaded dendritic cells
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,tumor specific antigen-loaded autologous dendritic cells
2020-09-18T04:25:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-wt1-tcrc4-gene-transduced-cd8-positive-tcm-tn-lymphocytes,Synonym:,autologous WT1-transduced CD8-positive Tcm/Tn lymphocytes
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC 122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC-122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Chemical structure:,"2,6-piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-"
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Avage
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Tazorac
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Retisol-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A Forte
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Vitinoin
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Code name:,AGN-190168
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Chemical structure:,"6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl EsterEthyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate"
2020-09-18T04:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avanafil,NA,NA
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,US brand name:,Avandia
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Abbreviation:,ROS
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Code name:,BRL49653
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Chemical structure:,"(+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1)"
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Synonym:,PDGFR alpha/KIT mutant-specific inhibitor BLU-285
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,US brand name:,Ayvakit
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Code name:,BLU-285
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF humanized monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF rhuMAb
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BAT1706
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BEVZ92
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BI 695502
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CBT 124
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CT-P16
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar FKB238
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar GB-222
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HD204
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HLX04
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar IBI305
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar LY01008
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MB02
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MIL60
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar PF-06439535
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar QL 1101
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar RPH-001
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar SCT510
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar TRS003
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,"immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer"
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,recombinant humanized anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Avastin
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Mvasi
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Zirabev
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMab-VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Code name:,HD204
2020-09-18T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425,US brand name:,Doptelet
2020-09-18T04:26:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream,US brand name:,Aveeno cream
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Avelox
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Viagmox
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Abbreviation:,MOXI
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Code name:,BAY 128039
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Synonym:,anti-PD-L1 monoclonal antibody MSB0010718C
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,US brand name:,Bavencio
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Code name:,MSB0010718C
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,US brand name:,Avemar
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Foreign brand name:,Avemar
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Acronym:,FWGE
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Avinza
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Infumorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Kadian
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MS Contin
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MSir
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph SR
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Roxanol
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Statex SR
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,Abbreviation:,MORPH
